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ABSTRACT OF DISSERTATION

CHANGING THE PERSPECTIVE IN MANAGEMENT OF A PROGRESSIVE
NEUROLOGICAL DISORDER: DEVELOPING INTERVENTIONS TO TARGET
MULTIFACTORIAL COMPONENTS OF PARKINSON’S DISEASE WITH
EMPHASIS ON IMPROVING CLINICAL MEANINGFUL OUTCOMES
Neurological disorders are currently the leading source of disability in the United
States with Parkinson’s disease (PD) having the fastest growing incidence rate (Abate et
al., 2017). PD is the second most common degenerative disease in older adults above 60
years old (Tysnes & Storstein, 2017) and epidemiology reports predict that the number of
PD cases has doubled to 6 million since 1990 (Dorsey, Sherer, et al., 2018) It is estimated
that PD prevalence will continue to rise with a projected 60,000 new cases in the United
States by 2030 (Dorsey, Elbaz, et al., 2018) and has the potential to reach more than 12
million cases worldwide by 2040 (Dorsey, Sherer, et al., 2018).
PD is an incurable, progressive neurological disorder, that presents with both motor
and nonmotor symptoms that effects one’s functional mobility potential. The multifactor
impact of PD, including both motor and nonmotor features, has a negative effect on
functional mobility potential for individuals living with PD. Walking, a component of
functional mobility, becomes more difficult as the disease progresses. A once previously
learned automated task, is compromised secondary to a variety of motor deficits. In
addition, nonmotor symptoms can worsen motor complications, gait difficulties, disability,
and self-perceived health status (Dissanayaka et al., 2010; Pontone et al., 2009; Yamanishi
et al., 2013). Due to the various components of this disease, it can be difficult to choose
which interventions would be most beneficial for individuals with PD that are presenting
with walking problems.
The overall purpose of this research is to first explore the exercise habits of
individuals with PD to understand what type of exercise is being utilized to combat this
progressive neurodegenerative disorder that currently has no cure. It will aim to understand
how intense individuals are perceiving their workouts and what barriers exist to PD
symptom management. Neuroplastic fundamentals suggest that specificity of selected
exercise, repetition of activities and intensity of work can all positively impact direct
recovery after a neurological diagnosis. Furthermore, incorporating exercise at higher
intensities has been established as an intervention to improve functional mobility for

individuals with stroke, traumatic brain injury and spinal cord injury but little is known
about its impact with the PD population. This research will build on the knowledge gained
about current exercise habits and couple it with current best evidence to develop an
intervention that targets improving clinically meaningful outcomes with goals to address
the multifactorial components of PD.
KEYWORDS: Parkinson’s disease, exercise, intensity, self-efficacy
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CHAPTER 1. INTRODUCTION
Background
Parkinson’s disease (PD) is the second most common degenerative disease in older
adults, affecting 1-2% of individuals above 60 years old (Tysnes & Storstein, 2017).
According to the National Parkinson’s disease Foundation, 1 million people currently have
PD in the United States and 4-6 million people worldwide (Dorsey, Elbaz, et al., 2018). It
is estimated that the PD prevalence will continue to rise and there will be over 60,000 new
cases in the United States by 2030 (Dorsey, Elbaz, et al., 2018).
PD is an incurable neurodegenerative disease that is a result of a faulty basal ganglia
that causes a degeneration of dopaminergic neurons in the midbrain (Brundin & Lotharius,
2002). Dopamine, which acts to control everyday movement in healthy individuals, is
significantly reduced in individuals with PD, which results in motor impairments that
impact functional mobility. Cardinal features including bradykinesia, resting tremors,
muscular rigidity, and postural instability (DeMaagd & Philip, 2015b; Marsili et al., 2018)
are a result of this neurotransmitter problem. The combination of dopamine depletion and
motor cardinal symptoms create an inability to perform previous automimic tasks (Bello et
al., 2010), such as walking.
Even though PD is known for its classic motor symptoms, it also presents with
nonmotor symptoms that also impact functional mobility (Tysnes & Storstein, 2017). Non
motor symptoms such as fatigue, depression, mood disorders, apathy, and cognitive
disfunction (Park & Stacy, 2009) have all been reported with progression of PD. Though
PD is most recognized by its motor features, the nonmotor features also contributed to the
decline in functional mobility over time.
As the disease progresses, motor and nonmotor features of PD contribute to a decline
in walking problems which is a major burden that directly impacts independence and
quality of life (Mirelman et al., 2019). Gait in individuals with PD is impacted by common
motor features including decreased gait speed, increasing variability in strides, shorter step
lengths, longer double limb support time, decreased arm swing, and overall impaired
balance (Herman et al., 2005). Slow gait speed and reduced endurance is present with
individuals with PD, and it has detrimental consequences that limit participation in the
1

surrounding environments outside the home. Even when individuals with PD are capable
of walking at the same speed as age matched healthy controls, they are unable to sustain
this velocity over longer distances (Canning et al., 2012).
Furthermore, non-motor features have been reported to directly impact these
common motor features of PD. Depression and anxiety, two common nonmotor symptoms,
occur in a significant proportion of individuals with PD and are positively correlated with
motor symptoms, motor complications, gait difficulties, freezing episodes, on-off
fluctuations, cognitive impairment, disability, worsening quality of life, and poor selfperceived health status (Dissanayaka et al., 2010; Pontone et al., 2009; Yamanishi et al.,
2013). These nonmotor measures are highly correlated with low self-efficacy, or
confidence, when it comes to disease management (Martikainen et al., 2006). Overall, both
the nonmotor and motor limitations in individuals with PD need to be addressed to improve
mobility and quality of life.
Currently, pharmacology interventions targeting dopamine replacement therapy is
considered the gold standard for treatment of PD (Canning et al., 2012; Ellis et al., 2013;
Fertl, 1993; Taylor & Betz, 1983). This is often the first line of defense and is prescribed
early on after initial diagnosis to help with management of the motor symptoms only. Shortterm pharmacology benefits are dramatic early on but are variable and do not address all
aspects of the disease process (Thanvi & Lo, 2004). Motor resistant symptoms, and nonmotor symptoms, quickly appear and become difficult to treat. Long-term benefits are still
uncertain and in some cases create new challenges such as fluctuations in motor responses,
dyskinesias (involuntary movements) and even worsening of gait (Mirelman et al., 2019).
Fortunately, exercise framed by long standing neuroplasticity principles, has been
shown to be beneficial in managing symptoms of PD but is not often considered a supportive
adjunct to the gold standard for treatment early in the diagnostic assessment. 138
participants living with PD were surveyed about suggested early intervention after being
diagnosed with PD and 95% (n=131) of them reported use of medication as the first line of
defense (Lockwich et. al, 2021). Adapting early interventions to emphasize neuroplastic
principles may provide benefits in managing common PD symptoms in leu of medication
usage. Neuroplasticity refers to the adaptive capacity of the brain to alter its structure and
function after damage by relearning behaviors through experience (Kleim & Jones, 2008).
2

These outlined principles provide guidance in creating an environment that allows the
‘plastic’ brain to rewire and relearn after a neurological injury. Neuroplastic fundamentals
suggest that specificity of selected exercise, repetition of activities, intensity of work as well
as salient activities can all positivity impact the direct recovery after a neurological injury
(Kleim & Jones, 2008). Exercise, targeting improving gait performance, must be a part of
the intervention as well as disease management education in treating PD, to reduce the
dependence on gold standard medication treatments that have lingering side effects and
long-term motor consequences. Frequent experiences with long term medication use include
a ’on-off phenomenon’ which results in periods of immobility and incapacity that is a direct
result of long term L-Dopa use and can worsen motor impairments (Kleim & Jones, 2008;
Schenkman et al., 2017). Reducing the dependence of L-Dopa decreases the likelihood of
these motor fluctuations and enables the individual to utilize alternative interventions, such
as exercise, where the benefits outweigh the risks.
Furthermore, exercise delivered at an increased intensity has been well established as
an intervention to improve gait performance in other neurological populations. Recent
clinical practice guidelines suggest incorporating moderate to high intensity walking
practice to produce meaningful clinical changes in walking for individuals with stroke,
traumatic brain injury and spinal cord injury (Hornby et al., 2019). Walking practice is a
task specific activity that if delivered at a high enough intensity can be critical in improving
walking speed and distance (Hornby et al., 2019). Walking as an intervention, focuses less
on impairments and more on a functional task that is utilized in everyday life.
This intervention highlights the importance of implementing gait performance
interventions in an environment that incorporates neuroplasticity principles to promote
change. However, little is known about the impact of intensity driven exercise in the PD
population to improve gait and there is even less reported on the benefits of targeting
additional nonmotor symptoms that couple this disability. To achieve sufficient outcomes,
higher levels of exercise intensity delivered in an environment that aims to address the
nonmotor symptoms of PD may provide the optional solution.
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Stating The Problem
Neuroprotective benefits of exercise in the PD population are possible despite the
progressive consequences of this neurodegenerative disorder. There is promising evidence
to also support incorporating intensity training into PD interventions (Schenkman et al.,
2017). However, these findings are primarily limited to improvements seen in gait
biomechanics and disease severity. It is unknown of their impacts on clinical based
outcomes, especially gait performance. Exercise used as an adjunct to standard care may
be beneficial in improving overall functional mobility in this population. However, the
level of intensity and proper delivery of these interventions is still unclear. Little has been
reported on the improvements in clinical gait measures after implementation of a moderate
intensity-based exercise program. There is a critical need to understand the impact of
intensity-based walking and the benefits of incorporating opportunities to boost selfefficacy in the PD population to discover adjunct interventions to help combat this
multifactorial neurological progressive disease.
Research Purpose & Approach
The overall goal to this research is to augment current PD interventions with a
moderate intensity driven task specific option that emphasis self-efficacy with the goal to
improve gait performance for individuals with PD. We plan to accomplish this by first
understanding what individuals with PD are currently doing for exercise and then use this
information to develop a moderate intensity-based walking program. The two specific
Aims for this research are as follows:
Specific Aim 1:
Investigate the current perceived exercise habits, frequencies, and intensities of individuals
with PD living in the community and understand the barriers to intensity training.

4

A survey was administered to individuals with PD living in the tristate region
including support groups and exercise programs that serve the PD population in the states
of Indiana, Kentucky and Illinois. The survey questions aimed to investigate perceived
exercise habits of individuals living in the community with PD, what individuals were
currently doing for exercise, how hard they were working out and what barriers existed
with current exercise habits. We hypothesize that individuals living in the community with
PD will report participating in exercise and describe experiencing intensity-based
symptoms only some of the time during routine exercise.

Specific Aim 2:
Determine the effectiveness of a moderate intensity driven walking program that targets
the multifactorial components of PD with goals to improve clinically meaningful
outcomes.
Five individuals with PD were recruited for this A-B-A-B withdrawal design study
to pilot an intervention targeting a unique population. PD is a highly variable diagnosis
with a wide array of presentations and symptoms. This design allowed for each participant
to act as their own control which considered the variability in PD. It was hypothesized that
participants living in the community with PD will demonstrate improvements in clinically
meaningful outcomes after participating in a moderate intensity driven walking
intervention when compared to baseline.
The following questions, breaking down the overarching hypothesis, aimed to
address the multifactorial components of PD:
1. Is there is a functional relationship between moderate intensity step training and
gait endurance for individuals with PD?
2. Does a moderate intensity step training program influence secondary clinically
meaningful outcomes, such as speed and balance, for individuals with PD?

5

3. Can a moderate intensity step training program that is provided in an environment
that incorporates opportunities for improved self-efficacy generalize to
improvements to perceived quality of life in individuals with PD?
Theoretical Approach
With Parkinson’s disease being a progressive, incurable neurological condition, it is
imperative to draw attention to the nonmotor features that accompany this disability. With
a majority of individuals with PD suffering from anxiety and depression, building up an
individual’s self-efficacy during the proposed intervention is a critical component in
achieving meaningful outcomes.
An individuals perceived self-efficacy is the innate, personal belief that they have
the capability to achieve levels of performance that exercise influence over events that
affect their own lives (Bandura, 1997). Self-efficacy beliefs determine how people feel,
think, behave, and motivate themselves. By obtaining a sense of control over an
individual’s situation, high self-efficacy beliefs are associated with improved human
functioning (Bandura, 1997). Unless individuals believe their actions can produce desired
effects, they have little incentive or motivation to undertake activities or persevere in the
face of difficulties (Bandura, 1997).
Healthy individuals who demonstrate high self-efficacy believe they can exert
control over stressful situations and tend to choose to perform more challenging tasks,
establish higher goals and adhere to them (Kanfer, 1991). These individuals tend to have
improved emotional well-being, demonstrate successful coping skills, participate in
healthy behaviors, score well on cognitive tests and are at a lower risk for mortality (Taylor
& Betz, 1983). Low self-efficacy may result in individuals withdrawing from difficult tasks
secondary to the greater risk of losing control over their situation (Bandura, 1997). These
individuals that doubt their capabilities could be because they are a victim of stress and
depression (Bandura, 1997).
Though exercise is a positive contributor to improving gait performance in
individuals with PD and is neuroprotective there are still factors that limit this potential.
Barriers to exercise still exist including low outcome expectation, fear of falling, lack of
time as well as poor motivation (Ellis et al., 2013). Individuals with PD also demonstrate
6

reduced levels of physical activity when compared to their healthy peers (Fertl, 1993). This
research focused on using both verbal persuasion and mastery of experience, `overall
motivation to achieve personal goals. By incorporating components of the self-efficacy
theory, individuals were able to maintain a positive attitude, increased their confidence and
become highly engaged in the intervention. Overall, this made for a strong commitment to
the research that was reflected in low attrition rates and 100% compliance across all
participants.
Operational Definitions
Parkinson’s disease: an incurable, progressive nervous system disorder that is characterized
by classic motor symptoms that directly affect movement (Mhyre et al., 2012).
Dopamine: a neurotransmitter found in the body that enables the brain to communicate and
control everyday movement (Mhyre et al., 2012).
Functional Mobility: a person’s physiological ability to move independently and safety, in
a variety of environments, in order to accomplish functional activities or tasks, and to
participate in the activities of daily living, at home, work and in the community (BouçaMachado et al., 2018).
Neuroplasticity: the ability for neurons found in the brain to alter their structure and function
in response to a variant of internal and external pressures, including behavioral training,
after injury (Kleim & Jones, 2008).
Intensity: amount of work per unit of time (American College of Sports et al., 2018).
Specificity: the selected nature of the training experience dictates the nature of the plasticity
(Kleim & Jones, 2008).
Salience: the selected training experience must be meaningful to the person in order to
induce plasticity. (Kleim & Jones, 2008
Maximum heart rate: 208-.7*age (Hornby et al., 2019).
Moderate Intensity Exercise: exercise that reaches 60-80% of an individual’s maximum
heart maximum (Hornby et al., 2019).
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High Intensity Exercise: exercise that reaches 80% or above an individual’s heart rate
maximum (Hornby et al., 2019).
Self-efficacy: the innate, personal belief that they have the capability and confidence
achieve levels of performance that exercise influence over events that affect their own lives
(Bandura, 1997).
Assumptions
It was assumed that:
1. All participants answered survey questions honestly about their current exercise
practices while living with PD.
2.

All participants were not utilizing any alternative intensity-based treadmill exercise
during intervention study.

Limitations
1. A convivence sample was chosen for both Aim 1 and Aim 2 studies and may limit
a true representation and generalization to the entire PD population.
2. All participants participated in their “ON” phase of their medications during Aim
2’s intervention to allow for the best tolerance to exercise and to adhere to protocols
from current supported research. This however may not accurately represent day to
day presentations of individuals with PD.
Delimitations
1. Participants for specific Aim 2 were selected only if they were diagnosed in the mild
to moderate severity stage of PD. This was chosen secondary to the fact that the
surrounding supportive research, as well as outcome measures, have not been
validated in the severe stage of PD.

8

CHAPTER 2. LITERATURE REVIEW
Introduction
Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disorder that
is quickly increasing in prevalence across the county. Neurological disorders are currently
the leading source of disability in the United States with PD having the fastest growing
incidence rate out of all of them (Abate et al., 2017). Epidemiology studies have reported
that the number of individuals with PD has doubled to 6 million cases since 1990 (Dorsey,
Sherer, et al., 2018) which is estimated to be an increase of 118%. The PD population is
rising steadily and it is projected that individuals living with PD will reach more than 12
million cases worldwide by 2040 (Dorsey, Sherer, et al., 2018).
Though the cause of PD is still unknown there are some possible risk factors that
have been identified that may be associated with this diagnosis. Age, specifically
individuals older then 65, pose more of a risk of developing PD when compared to younger
individuals (Tysnes & Storstein, 2017; Van Den Eeden et al., 2003). Gender also seems to
play a role, with males being more likely to develop PD. And finally, there has been some
identified environmental exposures, especially found in rural environments, that have
drawn the most attention as possible sources of risk in the past few years. Exposure to
industrialization chemicals, farming toxins such as pesticides and herbicides as well as
some other metals and solvents have thought to be associated with a PD diagnosis (Tysnes
& Storstein, 2017). However, the influence of environmental exposure is still poorly
understood. What we do know is that the US population is aging rapidly across the country
and that individuals with PD are living longer than once before secondary to advancements
in medical care (Haerens, 2014). The aging population that is now living longer could be
contributing to the rising incidence of PD in the population.
PD is classified as a motor disorder that is caused by a neurotransmitter reduction
in the brain that impacts mobility. Dopamine, the key neurotransmitter found in the brain
that controls movement, is reduced in individuals with PD (Santos et al., 2016). The
degeneration of dopaminergic neurons in the midbrain causes a disruption in the normal
flow that is responsible for correctly executing voluntary movements (Santos et al., 2016).
Neuropathology imagining also reveals the presence of Lewy bodies, which are an
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abnormal buildup of protein deposits, that are found to be also associated with Alzheimer’s
disease (Lees, 2012).The presence of Lewy bodies coupled with the loss of dopaminergic
neurons in the midbrain reduce the ability to control once learned voluntary movements
(Lees, 2012). This results in motor impairments that not only negatively impact previously
automated functional mobility tasks, such as walking (Rennie et al., 2018) but also impact
nonmotor features that are typically present with the disease. Even though PD is known for
its classic motor symptoms, it also presents with nonmotor symptoms that also impact
functional mobility (Tysnes & Storstein, 2017). Non motor symptoms such as fatigue,
depression, mood disorders, apathy, and cognitive disfunction (Park & Stacy, 2009) have
all been reported with progression of PD. Though PD is most recognized by its motor
features, the nonmotor features also contributed to the decline in functional mobility over
time.
Multifactorial Impact on Functional Mobility for Individuals With PD
PD is an incurable neurodegenerative disease that directly impacts an individual’s
movement that impacts their functional mobility potential and worsen with disease
progression. Functional mobility is defined as “a person’s physiological ability to move
independently and safety, in a variety of environments, in order to accomplish functional
activities or tasks, and to participate in the activities of daily living, at home, work and in
the community”(Bouça-Machado et al., 2018).
Until recently, functional mobility declines in individuals with PD was considered
to be a direct result of the primary motor impairments. But attention to the presence of
nonmotor symptoms that accompanies this disease has been investigated as another
contributing factor that impacts decline (Martinez-Martin et al., 2007). The severity of
motor and non-motor symptoms can significantly disrupt individual functioning, activity
level, and overall health-related quality of life (Duncan et al., 2014; Karlsen et al., 2000).
Quality of life is a multi-dimensional construct, which includes physical, mental,
and social domains. Quality of life in individuals with PD, often measured by a self-report
called the Parkinson’s Disease Questionnaire-39 (PDQ-39), is defined as the impact of the
disease through the perspective of the individual (Bushnell & Martin, 1999). Questions on
the PDQ-39 aim to ask individuals about the impact of PD multiple life domains including
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mobility, activities of daily living, emotional well-being, stigma, social support, cognition,
communication, and bodily discomfort (Bushnell & Martin, 1999; Opara et al., 2012). All
these domains can be directly impacted by the motor and nonmotor symptoms that are
present.
Motor Symptoms: Physical motor impairments that accompany PD are a direct
result of the dopamine depletion in the brain. Cardinal motor symptoms include
bradykinesia (slowness of movement), resting tremors, muscular rigidity and postural
instability (DeMaagd & Philip, 2015b). Other motor symptoms that have been reported
include gait disturbances, balance impairments and difficult with speaking and writing
(Moustafa et al., 2016).
All these classic cardinal motor impairments have a direct impact on day-to-day
functional mobility for individuals with PD and are well documented and understood.
Individuals with PD have difficultly coordinating movement for previously learned
automated tasks, especially walking. Walking ability is often impacted by decreased speed,
increasing stepping variability, shortening step lengths, increasing double limb support
time and overall impaired balance (Arthur & Donelan, 2010). Not just the quality of
walking, but the ability to sustain the amount of energy required to complete walking tasks
is also reduced. Walking endurance has been reported to be significantly less for
individuals with PD when compared to heathy adults (Falvo & Earhart, 2009). Canning et
al. (2012) found that individuals with PD are unable to sustain this walking velocity over
longer distances when compared to age matched norm. Limitations in walking
requirements that are needed for everyday life impede potential for independence after
diagnosis.
The onset of these motor features develop at a point where individuals are usually
diagnosed with PD (DeMaagd & Philip, 2015a). But unfortunately, once these symptoms
start to appear and there is a notable disruption in mobility, there has already been a steady
progression unfolding neurologically (DeMaagd & Philip, 2015a). When individuals first
complain of motor symptom involvement, there is already a 50% loss (Marsden, 1990;
Ross et al., 2004) in dopaminergic neurons with some individuals reaching losses up to 6070% (Dauer & Przedborski, 2003). The symptoms of PD tend to lag the initial occurrence
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of the disease by an estimated 4-5 years (Ross et al., 2004). Therefore, when individuals
with PD are seeking out assistance because of functional mobility declines, they are already
far a long in the disease progression without even knowing it.
Non-Motor Symptoms: In addition to the motor symptoms, there are a variety of
nonmotor symptoms that impact living with PD as well. Nonmotor symptoms include, but
are not limited to taste changes, bowel and bladder dysfunction, memory loss, trouble
concentrating, loss of interest, hallucinations, and sleep disturbances (Martinez-Martin et
al., 2007).
However, neuropsychological symptoms are some of the most reported nonmotor
manifestations that are both detrimental to functional mobility potential and selfmanagement behaviors. Depression and anxiety disorders occur in a significant proportion
of individuals with PD and are positively correlated with motor symptoms, motor
complications, gait difficulties, freezing episodes, on-off fluctuations, cognitive
impairment, disability, worsening quality of life, and poor self-perceived health status
(Dissanayaka et al., 2010; Pontone et al., 2009; Yamanishi et al., 2013). Both depression
and anxiety have been reported to reduce working capacity more than the classic motor
features that typically define this diagnosis and are also highly correlated with low selfefficacy when it comes to disease management (Martikainen et al., 2006).
Self-efficacy, or the confidence that one has in their ability to control their lives, is reduced
for individuals with PD when compared to their healthy peers (Toglia et al., 2020).
Individuals with PD often report feelings of apathy, or lack of motivation, when it comes
to participating in self-management activities. When asked about living with PD, a
qualitative study reported common complaints of reduced interest and desire to participate
in normal activities that they did before prior to being diagnosed (Pluck & Brown, 2002).
Individuals with PD also appear to have problems with initiation of activities and present
with an overall flattened affect or mood (Pluck & Brown, 2002). Self-efficacy has been
linked to self-management behaviors in multiple chronic diseases, with those individuals
having lower self-efficacy lacking the initiation to seek out behaviors that will help manage
their chronic conditions (Chan, 2021; Yoo et al., 2011). Poor motivation may lead to less
interest in seeking out self-management techniques, such as exercise, to gain control over
the progressive nature of PD.
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Burden of Multifactorial Symptoms on Opportunities to Battle PD
Ideally, self-management of PD requires the person to be knowledgeable about
their illness and make the appropriate decisions to seek out available interventions that are
needed for proper health management (Bodenheimer et al., 2002). Participating in physical
activity and exercise has been identified as a key self-management tool to reduce disease
severity for individuals with PD (Crotty & Schwarzschild, 2020). A longitudinal cohort
study evaluated the association between physical activity and progression of PD symptoms
and found that individuals with PD that exercise on a regular basis demonstrated a slower
progression of motor symptoms (walking and balance) as well as nonmotor symptoms
(quality of life, anxiety and depression) (Paul et al., 2019). Rafferty et al. (2017) found
similar results reporting that individuals with PD that consistently exercised showed a
substantial positive impact on health-related quality of life measures as well as
improvements in functional mobility. In addition, the Parkinson’s Foundation initiated a
quality improvement project in 2014 that was designed to develop a database that identified
successful options for great care across the country(Roberts et al., 2021). Building on this
registry study, Oguh et al. (2014) used the database to identify the impact of exercise on
mobility outcomes by comparing individuals with PD that were non exercisers (0
min/week), low exercisers (1-150 min/week) and regular exercisers (>150 min/week). An
exploratory analyses revealed that individuals with PD who exercised more then 150
minutes a week demonstrated better quality of life, physical function, slower progression
of the disease and less cognitive decline when compared to no or minimal exercise (Oguh
et al., 2014). Lifestyle changes, such as participation in regular exercise after a PD
diagnosis, seems to be viable option not only improve symptoms of PD but to slow down
the disease progression and improve long term outcomes.
But even though exercise provides a way to manage life with PD, the multifactorial
impact of symptoms can impact both engagement and confidence in these recommended
opportunities that could warrant positive results. Participating in self-management
behaviors is directly influenced by an individual’s overall confidence in their capabilities
to manage disease progression (Chenoweth et al., 2008). Confidence, or self-efficacy, a
lone has been identified as a factor that controls chronic illness management (SchulmanGreen et al., 2012) and can be impacted in many ways. Identified barriers to confidence in
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chronic disease management such as lack of knowledge, overwhelming new situations and
limited time with healthcare practitioners can negatively impact ones belief that they can
take action and reach meaningful goals (Farley, 2020). If individuals do not have the
confidence, or the innate belief, to control their own lives, then this can lead to diminished
life satisfaction, self-esteem, physical health, functional status, and quality of life (Veenstra
et al., 2005). Confidence with participating in daily mobility tasks is poor for individuals
with PD and associated with worsening of motors symptoms which can lead to an increase
in fall risk and poor quality of life (Mak & Pang, 2009).
In fact, altered heath related quality of life for individuals with PD has been shown
to restrict mobility opportunities which can also lead to social isolation (Duncan et al.,
2014). Social isolation is defined as having a small social network and/or infrequent
participation in social activities outside the home that can produce feelings of loneliness
(Cornwell & Waite, 2009). Social isolation can exacerbate PD symptoms, worsen mobility
potential and increase the risk to develop other health problems such as depression and
cognitive decline (Frisina et al., 2008). A qualitative study completed by Sjödahl
Hammarlund et al. (2018) found that both compromised social participation and
deteriorating physical functioning impacted everyday quality of life for individuals living
with PD. Social isolation has also been associated with worsening patient reported PD
severity levels and has been identified as a better predictor of quality of life when compared
to routine motor assessments (Subramanian, 2020). Less opportunities to be social
secondary to having a PD diagnosis may limit opportunities to participate in activities that
could improve health outcomes and in turn, can ultimately increase ones sedentary
behavior.
Social isolation has been found to be associated with greater sedentary behavior
and reduced physical activity in older healthy men and women (Schrempft et al., 2019).
Though we know little about this direct relationship in individuals with PD, we do know
that there is a increase is sedentary behavior with disease progression. The daily step count
for individuals with PD tends to decrease, with physical activity levels reaching 30% less
with disease progression (Cavanaugh et al., 2015; Ellis et al., 2013). On average,
individuals with PD have been reported to take 2,300 less steps then their age-matched
peers (Lord et al., 2013). Multiple studies have also reported that individuals with mild to
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moderate PD spent 75% of their day participating in sedentary behaviors and only 5% of
the day activity incorporating moderate or high intensity activities (Benka Wallén et al.,
2015; Chastin et al., 2010; Lord et al., 2013). As a result of disease progression and severity
of both motor and non-motor symptoms, activities of daily living, socialization,
productivity, employment, and health-related quality of life for individuals with PD can be
dramatically impacted (Hartley et al., 2014; Lawrence, Gasson, Kane, Bucks, & Loftus,
2014). This vicious cycle of social isolation and increased sedentary behavior can find
individuals in an environment that worsen disease progression.
Gold Standard Treatment Routed in Old Medical Model Perspectives
Fortunately, medical advancements have provided opportunities to manage
disability and the symptoms that accompany PD. The definition of disability has been
widely discussed and adapted over the past decades to encompass multiple perspectives.
The old medical model of disability was the most widely accepted communication tool
across the healthcare continuum for most of the 20th century (Beaudry, 2016; Hogan, 2019).
This model was heavily driven by diagnosis and the focus was on the individual and their
physical condition. Disability was viewed as a direct result of an individual’s intrinsic
conditions, such as the physical diagnosis and presence of symptoms, where blame was put
back on the individual for their current health state (Hogan, 2019). Little to no attention
was given to possible extrinsic circumstances that could be contributing to an individual’s
disability and there were no regard concerning alternative opportunities for disease
management (Beaudry, 2016; Hogan, 2019). Medical intervention targeted at disability
pathology sought to find a way to alleviate or ‘cure’ the diagnosis with options that
included pharmacology or surgery management. Closely related adapted models of
disability, such as the Nagi’s disability model (NAGI) developed in 1976, provided a linear
definition of disability, that left individuals with little control over their current health
situation (Snyder et al., 2008). Based on old medical model views, individuals had a
passive role in their disability management and little control over seeking out additional
opportunities to improve their overall health status (Hogan, 2019).
Current gold standard treatment that is available for individuals with PD is aimed
at alleviating the pathology directly (Mercuri & Bernardi, 2005), which is a similar
15

perspective of the old medical model’s view. PD treatment is focused on utilizing
pharmacology management early in the disease progress (Mercuri & Bernardi, 2005).
Currently, administration of the pharmaceutical drug Carbidopa-Levodopa (L-Dopa) is the
most prescribed medication for individuals with PD and is often the initial go to therapy
(Mercuri & Bernardi, 2005). L-Dopa, a dopamine replacement agent, became
commercially available back in 1975 and provided an opportunity to ease mobility
symptoms (Alberts & Rosenfeldt, 2020). This medical advancement made substantial
changes in PD management and expanded the life span for individuals with PD (Alberts &
Rosenfeldt, 2020). The use of L-Dopa therapy is still considered the gold standard today
50 years later (Mercuri & Bernardi, 2005) and directly targets replacing dopamine, the
main source of Parkinson’s disease pathology.
However, L-Dopa has only been shown to be effective in treating the motor
symptoms of PD such as bradykinesia, tone, and tremors. L-Dopa does not improve the
non-motor symptoms of PD and does not reverse the progression of the depleting
dopaminergic neurons in the brain (Snyder & Adler, 2007). At times, the side effects from
this drug can even worsen the motor symptoms themselves (Nose et al., 2017). The most
reported side effect are dyskinesias, which are abnormal voluntary movements that cannot
be controlled (Nose et al., 2017). Other side effects include dizziness, loss of appetite, dry
mouth, and confusion all which could impact mobility in individuals that already have a
motor disorder (Nose et al., 2017). Dry mouth, often a result of dehydration, has been
linked to poor lower extremity performance on measures of endurance and has been shown
to decrease overall exercise tolerance (Andrianopoulou et al., 2015). Poor appetite can lead
to malnutrition which is associated with an increased risk for functional decline and
mobility limitations (van der Meij et al., 2017). Furthermore, individuals frequently
experience a ’on-off phenomenon’ which includes periods of immobility and incapacity
and are present as the dosages of medication are wearing off (Lees, 1989; Nose et al.,
2017). These motor fluctuations require close monitoring and frequent adjustments of
medication (Poewe, 1994) . Unfortunately, L-Dopa’s impacts on motor impairments tend
to also reduce over time and the long-term benefits are poorly understood (Marsden, 1994;
Poewe, 1994).
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Despite modern treatment advances, the impact of the PD still increases as the
disease progresses. This may be because current PD management fails to address all
aspects of the disease progress and only targets the motor symptoms (Snyder & Adler,
2007). Due to a lack of treatment options, non-motor symptoms may present some of the
most significant challenges for individuals with PD (Smith et al., 2012). The PD nonmotor
symptoms can be as detrimental as the motor symptoms for overall patient health and
quality of life and cause difficulty with day-to-day management. Despite its limitations,
the introduction of pharmacology intervention in 1975 did help advance the management
of PD but also exposed obstacles in providing interventions that target the broad spectrum
of disability that encompasses this disorder. There is a need to explore alternative options,
such as exercise, to address the multifactorial presentation of PD disability.
Neuroplasticity: The Prescription of Exercise in the Neurological Population
The use of exercise utilized in the correct environment as an adjunct to standard
pharmacology care may provide the optimal solution to overcome obstacles and limitations
of current PD management. The benefits of exercise that are attainable for individuals with
a neurological disorders are possible due to the introduction of the concept of
neuroplasticity (Kleim & Jones, 2008). Neuroplasticity, the capacity of the brain to change
and adapt in response to intrinsic and extrinsic factors, provides solutions for individuals
with neurological conditions, to control management of their disability (Shaffer, 2016).
These outlined principles of neuroplasticity recognized the brain was not rigid, but rather
plastic, and has the capability of changing when provided with the optimal environment.
Kleim and Jones (2008) recognized that one’s environment can have a substantial
impact on recovery. Similar views were established by the World Health Organization
(WHO) in which a new perspective on how we view disability was developed. The
International Classification of Functioning, Disability and Health (ICF) framework,
instituted by the WHO in 2001, moved away from old medical model views that only
considered impairments because of one’s medical diagnosis. Rather, the ICF model
proposed to recognize disability as a comprehensive system in which one’s environment
and/or personal factors could either facilitate or hinder one’s overall functioning potential
(Chan, Cordoso, et al., 2009) (Peterson, 2011). Environmental factors are defined as “the
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physical, social, and attitudinal environment in which people live and conduct their lives,”
(WHO, 2001, p. 171). These environmental factors can either facilitate or create barriers
in an individual’s functioning and disability at the body functions and structures levels and
the activities and participation levels. Adapting this definition to incorporate exercise
recommendations for individuals with PD in Kleim and Jones (2008), the physical
environment that is available for an individual exercise in, should provide opportunities
that will facilitate optimal results.
This new recognized ability for the brain to form and reorganize synaptic
connections after a neurological injury changed the way neurorehabilitation interventions
were prescribed. Exercise should be practiced in repetition and individuals should be
allowed opportunities for continued performance of a skill over time to reach levels of
improvement that the brain can recognize as gains (Kleim & Jones, 2008). Exercise should
also be intense enough to induce a cardiovascular response in order to challenge the body
to improve (Kleim & Jones, 2008). Choosing exercise that is specific to what an individual
wants to improve should be included in order to rewire the brain (Kleim & Jones, 2008).
Finally, salient activities, or meaningful experiences, should be included to maximize full
engagement and motivation of participation (Kleim & Jones, 2008). These outlined
neuroplastic influences provide optimism for improved functional outcomes in the
neurological population.
Recent published clinical practice guidelines have incorporated these principles
when developing exercise prescriptions in neurological rehabilitation. Incorporating
repetitive, task specific exercise at moderate to high intensities has been recently
established as an intervention to improve clinical based outcomes for individuals with
stroke, traumatic brain injury and spinal cord injury (Hornby et al., 2019). Heart rate, an
easily recorded measure of intensity, can provide parameters to structure interventions at
different levels of work (American College of Sports et al., 2018) Moderate intensity
exercise is defined as work at 60-80% of an individual’s maximum heart rate where
maximum intensity levels incorporates levels above 80% (American College of Sports et
al., 2018). Intensity of exercise, as well as repetition and specificity, have been identified
as vital components to the exercise prescription for individuals with neurological disorders.
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Though the PD population was not included in the clinical practice guidelines,
exercise utilizing neuroplasticity principles, has also been shown to be beneficial in
managing symptoms of PD (Fox et al., 2006). Fox et al. (2006) suggested key exercise
principles that can enhance neuroplasticity for individuals with PD. These principles
include providing exercise opportunities that are intense enough to maximize synaptic
plasticity, challenging enough to promote structural adaptation and rewarding enough to
increase dopamine levels neurologically (Fox et al., 2006). The key findings here suggest
that exercise framed by neuroplastic principles should be utilized to see significant changes
for individuals with PD (Fox et al., 2006). Providing exercise as a supplement to current
pharmacology interventions, may provide an optional situation to improve in mobility for
individuals with PD (Fox et al., 2006).
Exercise as Prescribed Medicine to Supplement the Gold Standard for Individuals with PD
Fortunately, over the past decade, recommendations for individuals with PD to
avoid a sedentary lifestyle have been encouraged. Lee (2005) suggested that engaging in
daily physical activity alone, which is defined as any movement that requires energy
expenditure, can improve symptoms of PD. Not surprising to note, that even early
observations made back in 1986 by the 19th century neurologist, Jean-Martin Charcot,
recognized that movement alone seemed to reduce symptoms of PD (Goetz, 1986), after
noting patients reduction in symptoms following a ride in horse drawn carriage (Goetz,
1986). Even in some of the first unraveling understandings of PD, movement seemed to
also be a key player in PD management.
There is a growing body of evidence to suggest that incorporating movement in the
form of exercise can clinically improve symptoms of PD and should be recommended early
due to its neuroprotective benefits. Performing exercise, which is specific, planned,
structured and repetitive with the set intention of making improvements in goals is
recommended for all stages of PD (Lee, 2005). A large meta-analysis looking at the
benefits of exercise for individuals with PD, reported improvements in physical
functioning, health-related quality of life, strength, balance and gait speed after
participating in exercise when compared to usual care (Goodwin et al., 2008). Allen et al.
(2011) and Sanzo et al. (2021) reported that exercise was helpful at not only improving
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cardinal motor symptoms of PD, such as bradykinesia and postural stability, but also
nonmotor symptoms including quality of life. Multiple studies have also demonstrated
reduction in disease rating scales after participating in exercise (Ridgel & Ault, 2019;
Ridgel et al., 2015; Ridgel et al., 2008) and have pointed out the benefits of aerobic exercise
in inducing cortical changes within the brain (Alberts et al., 2016; Beall et al., 2013). These
key studies support the use of exercise to manage life with PD and provide an opportunity
to supplement current gold standard treatments in management of PD.
Even though benefits of exercise are well understood as a beneficial option in PD
management, research regarding the impact of interventions that utilize specific
neuroplastic principles is limited in the PD population. It is poorly understood what
individuals are doing for exercise and what knowledge they have about selecting the best
evidence-based options. Even less is understood about the impact of these interventions on
clinically meaningful outcomes.
Only a handful of studies (Clarke et al., 2016; Frenkel‐Toledo et al., 2005; Ridgel
et al., 2008; Schenkman et al., 2017) have delivered interventions that utilize neuroplastic
principles outlined in the clinical practice guidelines that recommend incorporating intense
task specific exercise interventions to induce clinical changes (Hornby et al., 2019).
Schenkman et al. (2017) is the only study to date to our knowledge that has incorporated a
high intensity walking program for individuals with PD that resulted in disease severity
reductions and improved gait biomechanics. Frenkel‐Toledo et al. (2005) found that when
compared to a control group or usual care, a moderate intensity-based walking program
reduced disease rating scores and improved step variability, step length and arm swing.
Clarke et al. (2016) reported that traditional low dose, patient centered, goal-directed
therapy in patients in early stages of PD did not seem to be effective at managing symptoms
of PD. However, another study reported that individuals with PD that participated in forced
exercise at higher intensities when compared to usual voluntary exercise showed global
improvements in motor function on clinical PD disease rating scales (Ridgel et al., 2008).
The key findings in these studies support the use of intensity-based exercise to make
marked improvements in motor symptoms of PD but needs to be investigated more.
Primary outcome measures of interest in the select few studies that have
implemented neuroplastic principles of exercise for individuals with PD are mostly limited
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to gait biomechanics and disease severity. The most common reported outcomes that
analyze gait biomechanics include gait speed, step length, gait variability and arm swing.
The Unified Parkinson’s Disease Rating Scale (UPDRS) has also been the most utilized
outcome to measure disease severity which assesses the impact of PD on subscales of
intellectual function, activities of daily living, motor, and motor complications (Bloem et
al., 2001).
Gait biomechanics and disease severity give us important information about the
impact of PD but do not address the entire clinical picture. Recently, a neurological core
set of outcome measures was published and recommend to being collected with all
neurological patients to address clinically meaningful outcomes that impact everyday life
(Moore et al., 2018). The core set includes the 10-meter walk test (10MWT) for gait speed,
six minute walk test (6MWT) for walking capacity, five times sit to stand (5XSTS) for
strength, the Berg Balance Test (BERG) for balance, the functional gait assessment (FGA)
for function and the Activities of Balance Confidence (ABCs) as a self-report of balance
ability (Moore et al., 2018) All of these tools have been validated in the PD population
(Duncan et al., 2014; Steffen & Seney, 2008) but are not commonly assessed in intervention
studies. The neurological core set needs to be further investigated to understand impact of
exercise on clinically meaningful outcomes that assess everyday life with PD.
Changing the Direction of PD management: Adopting a Holistic Perspective
Pharmacology management is still considered the first line of defense against PD
regardless of other possible identified sources of management (Gray et al., 2014;
Katzenschlager & Lees, 2002; Zablocki, 2005). To increase the awareness and
participation in other interventions, such as exercise, there needs to be a change in
perspectives regarding PD management and a shift away from old medical model views in
which pharmacology holds the only solution. Adapting the way we view PD disability,
through the ICF model perspective, may provide an intervention solution that targets all
aspects of PD. Figure 2.1 presents both perspectives of PD management with the current
old medical model view and then the proposed new ICF model framework solution that
incorporates a holistic approach that adds exercise to the prescription while addressing both
the environmental and personal factors that encompass PD.
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Figure 2.1 PD Management From Two Different Perspectives

PD management first from the old medical model’s perspective (A) demonstrating a linear
relationship between pathology and disability. The second perspective (B), adapted from
the ICF model framework, recognizes PD as a multifactorial disability that requires a
multifactorial intervention emphasizing exercise, environment, and personal factors as
adjunct to standard pharmacology care.

A multifactorial approach to address all aspects of PD is needed to address this
multifactorial disorder. Interventions that utilize exercise framed by neuroplastic principles
to strengthen connections, provided in a enriching environment that incorporates one on
one physical therapy care, and addresses nonmotor personal factors may be the optimal
solution.
Prescription of exercise: Though there are known benefits to exercise, the
utilization for PT services for individuals with PD is considerable low. Fullard et al. (2017)
completed a large analysis of 174,643 individuals that were diagnosed with PD and found
that 75% of the surveyed population did not utilize PT services over a 3-year period. In
fact, neurologists, who are the primary healthcare provider and the first stop for a PD
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diagnosis, do not routinely recommended exercise for management. One study found that
there was only a 7% chance for individuals with PD to be referred to exercise and only
40% chance over a period of six months (Keus et al., 2004). Lack of prescribed exercise
could devalue the benefits exercise which could also reduce motivation for individuals to
improve their outcomes (Keus et al., 2004). Exercise, as an adjunct to current
pharmacology care, needs to be a part of the conversation for PD management and
prescribed when treating symptoms of PD. Not only exercise, but interventions that drawn
on neuroplastic principles including intensity, repetition, and salient activities need to be
added to see the most benefits in clinically meaningful outcomes. There needs to be a
change in conversation regarding PD management provided by healthcare providers to
promote engagement and confidence in exercise to promote overall beneficial outcomes.
Environment: The American Academy of Neurology advocates not only for
individuals with PD to participate in exercise to manage symptoms of PD, but also
recommended regular assessments to be completed in an environment in which a PT leads
the session (Cheng et al., 2010). Currently there are a lot of options in the community that
provide environments for group exercise that including programs such as Pedaling for PD,
Delay the disease and Rocksteady boxing. Though these programs provide exercise
opportunities for individuals with PD, it may be beneficial to seek out additional
individualized opportunities as well. One study compared the success of exercise for
individuals with PD in individualized, home based and group environments (King et al.,
2015). Individualized PT exercise, when compared to the other two, was found to show
significant improvements in functional and balance outcomes (King et al., 2015). In
addition, another study found that forced aerobic exercise when compared to voluntary
exercise demonstrated improvements on motor performance measures with PD (Ridgel et
al., 2008). Administering exercise interventions in a personal, individualized way may
provide the optimal environment to see improvement in outcomes.
Personal factors: Finally, addressing the nonmotor symptoms of PD is needed by
targeting known barriers to exercise that currently exist. Known barriers to exercise such
as low outcome expectation and poor motivation have been found to limit participation in
exercise (Ellis et al., 2013). Low outcome expectations and poor motivation are commonly
expressed secondary to the progressive nature of PD when individuals are not expecting to
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see benefits (Shulman et al., 2008). Fear of falling, another common reported barrier, has
been associated with restricted activity levels (Bloem et al., 2001; Nilsson et al., 2010;
Nimwegen et al., 2011). Regardless of the known benefits to exercise, if barriers are not
addressed, then individuals will not seek out opportunities to manage life with PD.
Not surprising to note, that personal factors have been shown to impact exercise
behavior directly (Ellis et al., 2011). Self-efficacy, rather than disability, appear to be
strongly associated with whether ambulatory individuals with PD exercise regularly (Ellis
et al., 2011). Exercise self-efficacy not only is a substantial factor in both exercise
participation and long-term adherence to exercise programs (McAuley & Blissmer, 2000;
Williams & French, 2011), but is also a predictor of how much effort is put forth by the
individual. Lastly, persistence to overcome common barriers of exercise are also influenced
by ones self-efficacy (McAuley & Blissmer, 2000). Self-efficacy, or confidence in
achieving desired outcomes, is a common thread within the nonmotor symptoms of PD.
If interventions for individuals with PD provide an environment that boosts selfefficacy, there can be a substantial impact on the impairments, activities and participation
deficits that are present with disease progression. Providing opportunities to increase
confidence through mastery experiences, or personal experiences of success (Bandura,
1997), can be achieved by setting achievable goals and emphasizing achievements when
barriers are broken down. Verbal persuasion, another source of self-efficacy (Bandura,
1997), can be utilized by using positive feedback to draw attention to individual successes
which can enable individuals with PD to believe that they can achieve their outcomes. All
these factors can help achieve not only confidence in PD management but improve overall
motivation to continuing exercise throughout disease progression.
Conclusions
This literature review has defined the presentation of PD with emphasis on both the
motor and nonmotor symptoms that impact functional mobility. It has discussed the
progression of PD management over the past decades and the limitations that exist with
current PD management. Finally, it has drawn attention to the importance of incorporating
a multi factor intervention that incorporates evidence-based exercise strategies routed in
neuroplastic principles, opportunities to address personal factors by improving self24

efficacy and delivering interventions in a personalized environment to see meaningful
changes in PD. However, it has also exposed the obstacles and the limited information on
what we know about interventions for this population.
The research moving forward will seek to address these obstacles. Chapter 3 will
seek to understand what individuals of PD are currently doing for exercise so that programs
can be tailored, and knowledge can be shared about the best evidence-based options
available. Chapter 4 will look to deliver a moderate intensity-based intervention program
that incorporates self-efficacy strategies to understand its impact on functional mobility for
individuals with PD in the community. The intervention program will seek to utilize the
ICF model of disability perspective and adapt the recommendations to achieve a holistic
intervention that targets the multiple components of PD. Recognizing PD disability as a
disorder that requires a multifactorial intervention will help recognize that PD is not just
an intrinsic problem (Kostanjsek, 2011). It is through the interaction of the personal factors
and environment (Kostanjsek, 2011) that individuals with PD can start to gain some
confidence in their chosen exercise strategies and take back control over a progressive
disorder that does not have a cure.
Providing the most beneficial interventions for individuals with PD is challenging
due to the variety of symptoms that encompass this disorder. Both motor and nonmotor
impairments associated with PD directly impacts one’s functional mobility potential.
Despite the progressive nature of PD, this relationship between personal factors and
exercise offers optimism for individuals with PD and clinicians treating this disorder. This
relationship suggests that improvements are potentially modifiable. If we can exhibit
control over one’s exercise behavior then we can improve symptoms, regardless of the
defined disability. When designing intervention programs for individuals with PD, one
should include strategies to increase one’s exercise self-efficacy as well as functional
mobility for optimal achievable outcomes.
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CHAPTER 3. PERCEIVED EXERCISE HABITS OF INDIVIDUALS
PARKINSON’S DISEASE LIVING IN THE COMMUNITY.

WITH

Introduction
PD is the second most common degenerative disease in older adults, affecting 1% 2% of individuals above 60 years old (Tysnes & Storstein, 2017). According to the
National Parkinson’s Foundation, 1 million people currently have PD in the United States
and 4-6 million people have been diagnosed worldwide. It is estimated that the PD
prevalence will continue to rise and there will be over 60,000 new cases in the United
States by 2030.
PD is an incurable neurodegenerative disease that is characterized by cardinal
motor features including bradykinesia,

resting tremors, muscular

rigidity and postural

instability(DeMaagd & Philip, 2015b). These classic motor symptoms impact overall gait
performance and therefore need to be addressed to improve functional mobility (Herman
et al., 2005).
Gait problems are one of the most debilitating consequences of Parkinson’s disease
(PD) (Mirelman et al., 2019). With PD progression there is a complete inability to control
normal movement patterns that were once automatic. Walking, a previously automatic
motor task, is directly impacted and limits participation in mobility activities. These gait
problems are immense and are becoming a global problem with the rise in PD prevalence.
Fortunately, exercise targeting gait performance for individuals with PD is
neuroprotective despite the progressive consequences of this neurodegenerative disorder
(Ahlskog, 2011). Breaking down gait into biomechanical subcomponents allows for
targeted interventions to improve functional mobility. These subcomponents include limb
swing advancement, propulsion, stance control and lateral stability(Arthur & Donelan,
2010). Individuals with PD often have difficulty with the propulsion subcomponent and
demonstrate slow gait speed, shorter step lengths and poor adaptability to variable
environments. These propulsion deficits can impact one’s ability to participate in
community activities. Luckily, exercise targeting improving cadence has been identified as
a key variable to improving propulsion gait deficits in PD (Clarke et al., 2016).
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Furthermore, stepping practice at higher intensities with individuals with PD targets
improving walking performance whereas lower intensity, goal directed programs may not
(Frazzitta et al., 2009; Herman et al., 2007; Ridgel & Ault, 2019). Forced exercise at higher
intensities when compared to voluntary exercise produces global improvements in motor
function on clinical rating scales (Ridgel & Ault, 2019). When compared to a control group
or usual care, intensity-based training has improved disease severity motor scores, oxygen
consumption maximum levels, and cadence numbers as well as specific gait parameters
such as variability, step length and arm swing (Frenkel‐Toledo et al., 2005; Schenkman et
al., 2017). Practicing stepping at high-intensity levels of 80% of one’s heart rate maximum
(HRmax) or higher was found to be well tolerated with minimal adverse
effects(Schenkman et al., 2017). High intensity practice even produced a reduction in
disease severity motor scores where there was no demonstrated change with individuals
that trained at a moderate intensity level(Schenkman et al., 2017).
Improvements on disease severity has been well documented but little has been
reported on gait metrics at high levels of intensity-based exercise within the PD population.
The key difference in the findings support the use of high-intensity exercise to promote
adaptive changes in PD outcomes(Ridgel et al., 2015). However, the use of high intensity
stepping exercise is underutilized in current community programs, and the proper delivery
of these interventions is unclear.
Community programs available for individuals with PD consisted of group-based
exercise that focus on activities such as cycling, boxing, flexibility, and strength. Such
programs have shown to improve PD severity rating scores (Miller Koop et al., 2019;
Ridgel & Ault, 2019; Ridgel et al., 2015; Ridgel et al., 2008) but it is unclear about how
much effort the participant is actually putting forth. Though these programs tend to provide
a well-tolerated environment to improve motor impairments of PD, there is little emphasis
on measured intensity and task specific walking practice. Individuals with PD need more
options in the community to improve their walking and there are no current options
available.
It is unknown if individuals with PD that have gait problems are choosing the correct
type of exercise to improve their walking ability. The goal of this research to gain
knowledge that will help provide future education about choosing the most beneficial type
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of exercise to counteract disease progression impairments that are present. Also, despite
the known benefits of high intensity exercise, little is known about how much effort
individuals with PD are exercising. This understanding of perceived effort that is being
utilized during current exercise practice will provide reflection and guidance on the
adjustments needed for the exercise prescription. Finally, the results of this survey will be
used to tailor future walking exercise programs targeting high intensity stepping practice
for the PD community to improve walking.
Before additional community programs can be established, there is a critical need to
understand what individuals with PD living in the community are currently doing for
exercise. Therefore, the purpose of this survey aims to investigate the current exercise
habits and perceived intensities of individuals with PD. We hypothesize that individuals
with PD are not exercising at high enough intensities to induce changes in their walking
performance.
Methods
Study Design
A 22-question self-administered survey was emailed to a community-based sample
of individuals with PD living in the community. This project was approved by the
University of Kentucky and the University of Evansville Institutional Review Boards.
Study Population & Sample Size
A total of 202 individuals with PD were recruited from community-based
organizations in the Midwest region that served this rare neurological population.
Organizations included local support groups, exercise programs and local hospitals. There
is currently no national database that provides a PD population total in this US and the
prevalence of PD varies across the country. However, the Midwest area provides a unique
opportunity for investigating the PD population whereas the incidence was found to be 210x greater when compared to the western and southern counties (Wright Willis et al.,
2010).
Identified members of the PD community were granted access to the online survey
via a secure link sent from Qualtrics software programing, a widely used tool for survey
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research. Agreeable participants were asked to complete the survey if they had PD and
were given access via a secured online link after acknowledgment of an informed consent
was signed.
Study Outcomes
The survey was developed by the PI and a panel of clinicians and researchers. The
initial survey was piloted to individuals with PD and clinicians who treat individuals with
PD and was revised based on their feedback. The final survey consisted of 22 questions
that were separated in four blocks of interest (see appendix A). The first block asked basic
demographics questions and aimed to understand the individual’s current symptom
presentation and management strategies for their PD symptoms. The second block included
questions regarding their current level of function and walking ability after being diagnosed
with PD. The last two blocks aimed to understand current exercise habits and perceived
intensity levels. Intensity of exercise was defined as a presence of symptoms that include
sweating, shortness of breath, fatigue, muscle soreness, and early termination of exercise.
(Billinger et al., 2014) Level of intensity during exercise was categorized as either being
light, moderate or vigorous which was defined based on the Borg Rated Perceived Exertion
Scale parameters (Williams, 2017). Questions in the intensity block emphasized
understanding how intense individuals were exercising and if intensity symptoms were
produced with routine habits.
Statistical Analysis
All responses were anonymous and no identified information was collected.
Descriptive summaries were generated in the Qualtrics software and means/standard
deviations were reported for continuous variables. Categorical variables such as gender and
patient characteristic reported in the survey were summarized as frequencies and
percentages. Differences in disease severity were compared using a Kruskal-Wallis
analysis, as appropriate.
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Results
Study Population
Out of the 202 questionnaires successfully distributed to identified individuals with
PD living in the community, 138 were returned, yielding a response rate of 68%. Most
respondents were older than 60 years (91.7%, n=121), the majority were male (n=84), and
most had completed some form of higher education (92.1%, n=122). Nearly half of the
participants (n=62) have been living with PD for at least 6 years and most described their
PD symptoms as being mild to moderate on the disease rating scale (n=111). Few
individuals had received deep brain stimulation for management of their PD symptoms
(9%, n=12) but most utilized medication (94%, n=124). Mild, moderate, and severe PD
was represented in our respondents for this study. Though the majority of the respondents
reported mild (54%, n=57) to moderate (30%, n=32) PD severity, there was a small number
of individuals that reported living with severe progression of the disease (15%, n=16).
Table 3.1 describes the demographic characteristics of the respondents and their clinical
descriptions.
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Table 3.1 Demographic and Clinical Characteristics of PD Survey Respondents
Demographics
Percentage
Age >60y
91.7
Age > 70y
57.0
Gender (male)
63.6
Education (at least Bachelors or higher)
76.5
Lives with support
85.6
PD Diagnosis
2-4 y with PD
30.3
6+y with PD
47.1
PD Severity
H&Y 1-2 (mild)
47.8
H&Y 3-4 (moderate)
45.5
H&Y 5-6 (advanced)
6.8
Management of PD symptoms
Uses Medication
93.9
Number of Years on Medication (Mean ± SD)
6.73 ± 5.480
Has had Deep Brain Simulation (DBS)
10.0

Disease Severity
Survey respondents, regardless of disease severity, acknowledged participating in
some form of exercise during their daily routines. Though Kruskal-Wallis analysis revealed
there was a difference in the reported symptoms of perceived intensity when comparing
different PD severity levels. (see table 3.2) Individuals with mild PD were more likely not
to report if they experienced sweating during exercise [H(2)=8.368, P=.015] or had to stop
exercise because of intensity symptoms. [H(2) = 9.727, P=.008] Whereas individuals with
severe PD were in fact more likely to report these symptoms when participating in daily
exercise routines. Post hoc analysis revealed that there were no significant differences
found in perceived exercise intensity levels, duration, and dosage across disease severity.
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Table 3.2 Kruskal-Wallis Analysis and Mean Ranks Results of PD Severity Levels and
Reporting Intensity Symptoms With Exercise.
PD Severity
Mild
(n=57)

Moderate
(n=32)

Severe
(n=16)

P-Value

Exercise Intensity

53.47

54.36

48.59

.703

Heart Rate

54.03

49.59

56.16

.566

Sweating

59.41

49.70

36.75

.015

Shortness of Breath

51.65

47.95

67.91

.067

Fatigue

51.39

49.98

64.78

.198

Soreness

54.80

47.64

57.31

.339

Stop Exercise

47.55

53.75

70.91

.008

Intensity Symptoms

Summary of the symptoms of exercise intensity reported for individuals with varying
progression of PD severity (mild, moderate and severe) Sweating and stopping exercise
were found to be significant between individuals with mild PD and severe PD.

Walking Habits & Changes
Most individuals described their current level of functional mobility as independent
which was defined as the ability to walk on their own without the physical assistance of
another person, regardless of assistive device (71%, n=94; Figure 1).
The majority of the survey respondents participated in some form of exercise (87%, n=113)
including both individual exercise and group-based exercise programs. Seventy-five
percent of individuals reported when choosing what type of exercise to participate in, they
used walking for exercise over other modes of activity (n = 92). The most reported
environment to practice walking was outside of the home and in the community that
consisted of changes in surface types that challenged balance (66%, n=91). Few barriers
to exercising were reported and our respondents felt that there was nothing impeding their
ability to work out and routinely participated in exercise in their daily habits.
However, when asked about how PD had affected their walking, 65% (n=85) reported that
their walking has gotten worse since their diagnosis despite participating in routine exercise
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practice. Decreased speed (37%, n=51) and endurance (31%, n=42) were two of the most
common reported gait impairments that were attributed to the decline in functional
mobility.
Figure 3.1 Changes Current Walking Habits and Changes Reported With PD

Walking for Exercise

74.1

Walking Has Gotten Worse

64.9

Speed and Endurance
Impairments

43.8

0%

20%

40%
Yes

60%

80%

100%

No

Perceived Exercise Intensity
On average, individuals exercised at least 3 days a week (42% n=46) with some
reporting exercising at least 5 times per week (41%, n=45). Most exercise sessions lasted
at least 45 minutes (24%, n=27) with the majority being close to an hour in length. (55%,
n=61) When asked about how challenging their exercise was, most individuals answered
that they felt that they were exercising at a moderate intensity level (75%, n=81). Moderate
intensity exercise in this study was defined as breathing heavy but still able to hold a short
conversation while exercising(Williams, 2017).
Though individuals reported perceived exercise intensities at a moderate level,
reported symptoms did not support this finding. When asked to rate how likely it was for
them to display signs and symptoms of intensity during common exercise routines, over
half of individuals reported never or only sometimes displaying symptoms of sweating
(56%, n=61), shortness of breath (73%, n-100) and muscle soreness (5%, n=7) after
exercise. Only one respondent had to end exercise early (1%, n=1) because of these
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challenging symptoms of perceived exercise intensity. Figures 2 and 3 describe the
symptom provocation of the respondents during exercise.
Figure 3.2 Intensity of Exercise

Always
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Sometimes

Never
0

Stop Exercise
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Soreness
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Fatigue
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Shortness of Breath
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Sweating
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Report of the likelihood of symptoms of exercise intensity. Individuals were asked to rate
presence of exercise intensity symptoms during routine exercise on a 5 point like hart scale.
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Figure 3.3 Summary of Exercise Intensity Symptoms Reported
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Discussion
The objective of our survey was to investigate the current exercise habits of
individuals with PD and understand the level of perceived intensity that exercise was being
practiced. Despite the progressive nature of PD, exercise is both neuroprotective and a
positive contributor to improving mobility. Offsetting the sequence of this
neurodegenerative disorder, exercise has been shown to improve multiple aspects of
functional mobility, including gait (Miyai et al., 2002; Toole et al., 2005), balance(Ashburn
et al., 2007; Hirsch et al., 2003; Schenkman et al., 1998) flexibility(Schenkman et al., 1998)
and strength 35,33. Maintaining an active lifestyle alone has been linked to the preservation
of skeletal muscle mass strength regardless of the disease progression. (Martignon,
Ruzzante, et al., 2021) Reducing fall risk ((Ashburn et al., 2007; Protas et al., 2005; Toole
et al., 2005) Nonmotor symptoms of PD can also be impacted by exercise with
improvements reported and quality of life in this population
However, barriers to exercise still exist including low outcome expectation, fear of
falling, lack of time as well as poor motivation. (Ellis et al., 2013) Individuals with PD
have reduced levels of physical activity when compared to their healthy peers.(Fertl, 1993)
Avoiding a sedentary lifestyle and engaging in daily physical activity can improve motor
symptoms of PD.(Lee, 2005) Specific exercise, that is planned, structured and repetitive
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with the set intention of making improvements in goals, such as walking, is recommended
for individuals with PD to improve their health and well-being. (Rosenthal & Dorsey,
2013)
Overall, our results demonstrate that individuals with PD are motivated to
participate in exercise opportunities to manage symptoms of this progressive disease across
the spectrum of PD. Regardless of severity level, the majority of respondents with PD are
active and participate in some form of exercise at perceived moderate intensity levels.
Based on the small sample of this study, results indicated that severity level may not impede
the motivation or desire to exercise. Individuals with mild to moderate PD reported
exercising at the same level of perceived intensity and duration of those individuals that
had severe PD. Differences were reported however in intensity symptom experience.
Individuals with mild to moderate PD were less likely to experience intensity-based
symptoms during exercise and did not report it as frequently. Whereas individuals with
severe PD were more likely to experience symptoms of intensity and report needing to stop
exercise early. These results may provide information on proper dosage and how
interventions should be delivered at different levels of disease progression. Individuals
with mild to moderate PD may be able to be pushed at higher levels of intensity where
individuals with severe PD can workout at the same intensity level but may require rest
breaks and modifications to reduce intensity symptoms early on. Regardless of disease
severity level, intensity driven exercise seems to be a great option to combat PD symptoms
(Martignon, Pedrinolla, et al., 2021).
Despite practicing in daily exercise routines, the majority of respondents still noted
that their walking has continued to worsen since diagnosis. Degradation of walking
decreased walking speed and poor endurance were the most reported gait deficits by
respondents, even with routine daily exercise practice. This realization may indicate that
selected exercise practices are not directly targeting gait impairments that are present. Most
community-based PD exercise programs that are available aim to improve overall
generalized weakness, endurance, and mobility. But to our knowledge, there are no specific
programs that focus on walking directly. Outlined neurological principles advocate for task
specific, repetitive and salient practice to induce neuroplastic changes in the brain (Kleim
& Jones, 2008). Based on the results of this study, walking is absolutely a salient activity
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to individuals with PD. Therefore, individuals who want to improve walking should have
opportunities to practice walking.
Intensity of exercise is also a key component to induce neuroplastic changes (Kleim
& Jones, 2008). It was surprising to discover that the participants in our study perceived
that they work out at challenging intensities. The results of this preliminary study indicate
that individuals with PD may not be exercising at challenging enough intensities to produce
symptoms that are consistent with moderate to high intensity exercise. Typically, if
someone is to participate in challenging exercise, they will produce some level of intensity
symptoms that may include either sweating or becoming short of breath (Williams, 2017).
This was an unlikely occurrence with our participants despite reporting working at higher
perceived intensity levels. Research suggests that intensity-based stepping exercise is
beneficial for improving biomechanical gait impairments and decreasing disease severity
in PD. Schenkman et al. practiced stepping at high intensity (80% of an individual’s heart
rate maximum) and reported a reduction in PD severity scores compared to individuals that
worked at moderate intensity levels [60-80% heart rate maximum )(Schenkman et al.,
2017). When compared to a control group or usual care, another study found that intensitybased training has improved disease motor scores, oxygen consumption (Vo2 max),
cadence, and specific biomechanical gait parameters such as variability, step length and
arm swing (Ridgel & Ault, 2019). These results suggest that individuals with PD may need
to be pushed at higher intensity levels beyond their voluntary limits at rates
sufficient enough to
severity and

gait

induce

gait

performance

biomechanics has

changes. Improvements in disease

been well documented with intensity-

based exercise but little has been reported on clinical measures of gait propulsion
outcomes.
The mismatch between actual exercise habits and perceived levels of intensity may
be due to lack of awareness and education on what type of exercise one should be
participating in to improve their walking ability in the community. There is clearly a need
for more education regarding intensity levels of exercise and the benefits of pushing oneself
past voluntary limits to improve gait within the PD population. The results of this survey
demonstrate the need for exercise options that target high intensity exercise with emphasis
on improving walking in the PD population.
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Limitations
Though this preliminary study provided information regarding exercise practices,
there are limitations of this current study that are worthy of note. Survey data was obtained
through an online platform and individuals that did not have access to the internet were not
included, resulting in selection bias. These excluded individuals could have added more
variability to our sample, resulting in greater generalizability to the PD population as well
as more in-depth knowledge about current exercise habits for individuals with PD. Also,
generalizability of our results is limited given the heterogeneity of the subjects, as 90% of
the respondents were male, over 60 years old, and at a mild to moderate stage of the disease.
Finally, given that this was a self-report, only perceived exercise intensity levels were
analyzed, and true intensity measures were not collected. In the future, assessing direct
intensity measures this could give more insight into common exercise habits of those
individuals living with Parkinson’s disease.
Conclusions
In conclusion, our survey results have demonstrated that individuals with PD are
exercising regularly and using exercise to combat progressive symptoms. However, they
are still reporting worsening gait problems despite routine exercise habits practiced. Our
results suggest that individuals with PD are not exercising at challenging enough intensity
levels that are sufficient to induce gait performance changes.
Individuals with PD need more education and guidelines for options that include task
specific exercise to improve walking performance. Though there are many options for
individuals with PD to exercise in the community, to our knowledge there are no structured
walking programs available. Future studies will aim to utilize the results of this survey and
tailor a walking program with goals to improve overall gait within the PD community.
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CHAPTER 4. PUSHING THE LIMIT TO REACH MEANINGFUL CHANGE: THE
IMPACT OF INTENSITY DRIVEN EXERCISE IN INDIVIDUALS WITH
PARKINSON’S DISEASE.
Introduction
Neurological disorders are currently the leading source of disability in the United
States with Parkinson’s disease (PD) having the fastest growing incidence rate (Abate et
al., 2017). PD is the second most common degenerative disease in older adults above 60
years old (Tysnes & Storstein, 2017) and epidemiology reports predict that the number of
PD cases has doubled to 6 million since 1990 (Dorsey, Sherer, et al., 2018) It is estimated
that PD prevalence will continue to rise with a projected 60,000 new cases in the United
States by 2030 (Dorsey, Elbaz, et al., 2018) and has the potential to reach more than 12
million cases worldwide by 2040 (Dorsey, Sherer, et al., 2018).
PD is an incurable, progressive neurological disorder, that presents with both motor
and nonmotor symptoms that effects one’s functional mobility potential. Functional
mobility, an individual’s physiological ability to move independently to accomplish
functional activities at home, work and in the community (Bouça-Machado et al., 2018), is
impacted as direct result of this multifactorial disease. Classic cardinal motor features of
PD include bradykinesia, resting tremors, muscular rigidity, and postural instability
(DeMaagd & Philip, 2015b; Marsili et al., 2018). In addition to the motor symptoms,
nonmotor symptoms such as depression, anxiety, taste changes, memory loss, trouble
concentrating, loss of interest, hallucinations, and sleep disturbances (Martinez-Martin et
al., 2007) are also present with PD. The multifactor impact of PD, including both motor
and nonmotor features, has a negative effect on functional mobility potential for individuals
living with PD.
Walking, a component of functional mobility, becomes more difficult as the disease
progresses. A once previously learned automated task, is now compromised secondary to
a variety of motor deficits such as decreased speed (Blin et al., 1990; Morris et al., 1994),
reduced cadence (Baker et al., 2007; Blin et al., 1990; Morris et al., 1998), poor endurance
(Falvo & Earhart, 2009; Katzel et al., 2012) and increased gait variability (Giladi et al.,
2005). In addition, nonmotor symptoms of depression and anxiety correlate with these
motor symptoms, with one study reporting up to 56% of their surveyed PD population
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living with depression and 54% also demonstrating anxiety (Yamanishi et al., 2013). These
nonmotor symptoms can worsen motor complications, gait difficulties, disability, and selfperceived health status (Dissanayaka et al., 2010; Pontone et al., 2009; Yamanishi et al.,
2013). This couple effect of motor and nonmotor symptoms can limit motivation to
participate in activities that could provide opportunities to improve endurance which results
in overall sedentary behavior (Benka Wallén et al., 2015; Chastin et al., 2010; Lord et al.,
2013). Walking difficulty unfortunately worsens with disease progression and is a major
burden that directly impacts independence and quality of life (Mirelman et al., 2019). Due
to the various components of this disease, it can be difficult to choose which interventions
would be most beneficial for individuals with PD that are presenting with walking
problems.
Endurance training may be of interest secondary to recent mounting evidence that
has highlighted the substantial deficits found in individuals with neurological deficits.
Recommendations to include endurance exercise in daily routines has been well established
as an important part of the exercise prescription for individuals with neurological disorders
(Whelton et al., 2018). Endurance exercise has been shown to help maintain healthy weight,
increase stamina, reduce fatigue, reduce future health risks, strengthen the cardiovascular
system, improve mood, and help with managing chronic conditions (Whelton et al., 2018).
Poor endurance has been linked to deficits in not only functional mobility but strength, selfreported measures of physical activity, and even mortality in multiple populations, including
individuals with PD (Shearin et al., 2021).
Poor endurance, specifically in individuals with PD, may be a result of changes in
functional mobility that are directly related to the cardinal PD motor symptoms of tremor,
rigidity, hypokinesia, and postural instability (Penko et al., 2017). Physically altered gait
mechanics have been shown to cause a decrease in cardiovascular function which then
requires individuals to need a higher aerobic power to complete exercise at a lower intensity
(Schenkman et al., 2008). Measurements of oxygen consumption during walking have also
been reported to cause a steeper increase in V̇O2 ratings, or oxygen uptake, than healthy
controls across variable walking speeds (Penko et al., 2017). Furthermore, due to this
requirement of increased oxygen demand, individuals with PD tend to also expend up to
20% more energy when performing daily tasks (Schenkman et al., 2008). This domino effect
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results in poor walking efficiency and economy which leads to limitations in endurance and
other aspects of gait that is required for everyday activities.
Limited walking endurance in PD is also demonstrated in the distances captured by
the six-minute walk test (6MWT), the gold standard clinical measurement for endurance.
Average 6MWT distances traveled by individuals with PD was found to be around 391.6
+/- 99m (Falvo & Earhart, 2009) which when compared to normative values established
for healthy adults at distances of 572 +/-34m (Steffen et al., 2002) is less. And though
individuals with PD are able to achieve walking speeds that are similar to those of age
matched healthy peers, they are unable to sustain this velocity over longer distances
(Canning et al., 2012). Unfortunately, walking endurance is substantially impacted with PD
disease progression (Canning et al., 2006; Falvo & Earhart, 2009; Katzel et al., 2012) and
has detrimental consequences that limit the ability to move (Arthur & Donelan, 2010).
Focused interventions for improving endurance with individuals with PD may need
to be a part of the exercise prescription due its importance in achieving independence and
improved quality of life. Endurance, or the amount cardiorespiratory power exerted, is a
reflection on how long an individual can perform an activity without periods of fatigue or
use to secondary musculature to achieve the desired result (Jonas & Phillips, 2009). Regular
endurance exercise is recommended for heathy individuals to decrease the risk for future
health complications and suggested to be delivered at high enough intensities to induce a
cardiovascular response (Jonas & Phillips, 2009). The American College of Sports
Medicine also recommends that all adults need to exercise at least at 65% of their own heart
rate maximum in order to achieve improvements in overall cardiovascular fitness (Jonas &
Phillips, 2009).
Recommendations to increase intensity of exercise for the neurological population
has also been established in recently published clinical practice guidelines (Hornby et al.,
2019). Hornby et al. (2019) released guidelines for clinicians on how to improve locomotor
function following chronic stroke, incomplete spinal cord injury and brain injury. Strong
evidence supported the usage of intensity-based walking interventions whereas
incorporating strength, cycle and balance training was found to demonstrate weaker
evidence. Incorporating exercise at moderate to high intensities is suggested as an
intervention to improve clinical based outcomes, such as endurance measured by the
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6MWT, for individuals with stroke, traumatic brain injury and spinal cord injury (Hornby
et al., 2019). The neurological clinical practice guidelines, rooted in neuroplastic principles,
suggest that the brain has the capability to rewire after injury if given the optimal
environment to do so. Neuroplasticity, the capacity of the brain to change and adapt in
response to intrinsic and extrinsic factors, provides solutions for individuals with
neurological conditions to improve outcomes (Shaffer, 2016). Neuroplastic fundamentals
suggest that specificity of selected exercise and repetition of activities can all positively
impact not only gait but impact quality of life after a neurological diagnosis (Hornby et al.,
2016; Kleim & Jones, 2008). It is suggested that exercise should be practiced in repetition
and individuals should be allowed opportunities for continued performance of a skill over
time to reach levels of improvement that the brain can recognize as gains (Kleim & Jones,
2008). Exercise should also be intense enough to induce a cardiovascular response, resulting
in increased blood flow or heart rate, to improve cardiac output that will make the body
more efficient to perform exercise (Kleim & Jones, 2008). Choosing exercise that is specific
to what an individual wants to improve should be included in order to rewire the brain as
well (Kleim & Jones, 2008). Finally, salient activities, or meaningful experiences, should
be included to maximize full engagement and motivation of participation (Kleim & Jones,
2008). Experiences that are salient tend carry more importance to the individual which in
turn improves both attention and motivation (Kleim & Jones, 2008). These outlined
neuroplastic principles have changed the way neurological rehabilitation is utilized by no
longer viewing a neurological injury as a permanent disability. Rather, these neuroplastic
influences provide optimism for improved functional outcomes in the neurological
population by utilizing experiences to rewire brain recovery.
Though PD was not included in the clinical practice guidelines reported by Hornby
et al. (2019), the benefits of neuroplastic exercise and its impact on selected PD gait
biomechanics and PD severity levels can still be applied. Task specific cadence practice, or
the number of steps taken per minute, has been identified as a key variable that improves
PD gait biomechanics such as step length and step variability (Ridgel et al., 2015).
Repetitive cycle interventions have also demonstrated improvements on disease rating
scales, motor symptoms such as rigidity and bradykinesia and even manual dexterity
(Ridgel & Ault, 2019; Ridgel et al., 2015; Ridgel et al., 2008). As for intensity, individuals
42

with PD that participate in moderate to high intensity walking practice demonstrated
reductions in disease rating scores, step variability, step length and arm swing when
compared to a control group or usual care (Frenkel‐Toledo et al., 2005; Schenkman et al.,
2017). Another RCT found low dose therapy that including individual goal setting exercise
for individuals with mild to moderate PD not be an effective intervention for clinical
meaningful improvements in quality of life measured by the Parkinson’s Disease
Questionnaire (PDQ-39)

(Clarke et al., 2016). The PDQ-39 scores in this study

deteriorated by 2.5 points at 3 months and no difference in mobility gains at 15 month
follow up for those individuals that participated in low intensity, self-driven exercise
(Clarke et al., 2016). Lastly, forced exercise at higher intensities when compared to
voluntary exercise produced global improvements on motor symptoms as well as disease
severity rating scales (Ridgel et al., 2008). These studies support the use task specific
intensity driven exercise to manage select PD symptoms, but little is known about its role
and impact on the multifactorial components of this disease that impact everyday life with
PD.
Well documented improvements in disease severity and gait biomechanics after
participating in neuroplastic exercise has been established with individuals with PD, but
little has been reported on clinical gait outcomes of endurance and its impact on nonmotor
features that are also included in this multifactorial disorder. Though PD is most recognized
by its motor features, the nonmotor features also contribute to the decline in functional
mobility over time (Martinez-Martin et al., 2007). Both nonmotor symptoms of depression
and anxiety have been reported to reduce endurance capacity more than the classic motor
features that typically define this diagnosis (Martikainen, Luukkaala, & Marttila, 2006).
These nonmotor symptoms are highly correlated with low self-efficacy when it comes to
disease management (Martikainen, Luukkaala, & Marttila, 2006).
Self-efficacy, or the confidence that one has in the ability to control his or her life, is
reduced for individuals with PD when compared to their healthy peers (Toglia et al., 2020).
Mastery of experience and verbal persuasion have been identified as sources to improve
ones self-efficacy. Mastery experiences, or experiences that one gains when they take on a
new challenge and are successful, are one of the more influential sources that can improve
one’s self-efficacy by providing opportunities to practice skills (Bandura, 1997). Verbal
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persuasion, or positive feedback that is given while undertaking a complex task, can help
individuals believe that they have the skills to succeed (Bandura, 1997). In order to
motivate individuals with PD to participate in exercise opportunities that are intended to
improve endurance, utilizing these sources to combat the nonmotor symptoms may also
need to be addressed in selected interventions that also emphasis improving one’s selfefficacy to manage life with PD.
The purpose of this research is to investigate the effect of a moderate intensity
driven walking program on endurance that is provided in an environment that incorporates
opportunities for improved self-efficacy for individuals with PD. The moderate intensitybased intervention protocol will include walking practice on a treadmill that incorporates
both adjusted speed and incline to reach at least a moderate intensity level of exercise,
defined as 65% of an individual’s heart rate maximum. The primary goal of this study is to
provide alternative exercise options that address both the motor and nonmotor symptoms
of PD to improve clinical meaningful outcomes. Endurance deficits as well as confidence
in exercise need to be addressed so that individuals with PD can achieve improved
functional mobility.
Methods
Study Design
A single subject design was chosen for this study, which included a baseline
condition (A1), intervention condition (B2), withdrawal condition (A2) and a second
intervention condition (B2) (Portney & Watkins, 2000). Baseline conditions (A1) consisted
of outcome data collection only. Interventions phases (B1 & B2) included a moderate
intensity driven treadmill walking program delivered by a PT one-on-one in addition to
collection of both primary and secondary outcomes measures. The withdrawal phase (A1)
included a removal of the treadmill walking program and only outcome data collection.
This design was chosen not only to trial an intervention with a specialized neurological
population but to benefit from each participant acting as their own control. This design
allows for a dynamic platform to account for the vast variability within participant
presentations of PD. Lastly, this design was chosen to allow for two intervention periods,
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which ethically provided the most opportunity for individuals participating to achieve
possible benefits (Portney & Watkins, 2000). To address the nonmotor components of PD,
all conditions of this study were delivered in an environment that provided opportunities
to develop participant self-efficacy through mastery experiences and with guided verbal
persuasion, which have both have been identified as contributors to improving confidence
and belief in self-management of chronic disorder (Bandura, 1997). Both sources were
utilized during this study to achieve optimal outcomes. All study protocols were approved
by both the University of Kentucky and the University of Evansville Institutional Review
Boards.
Subjects
Five individuals were recruited for this study from a convenience sample of
individuals that were diagnosed with PD living in the Evansville, Indiana region. To control
for attrition rates, recruitment aimed at achieving a higher number of participants rather
than the recommended three for this particular design (Portney & Watkins, 2000).
Individuals that had mild to moderate PD were referred from local support and exercise
groups. PD disease severity was described by use of the Hoehn and Yahr scale (H&Y
Scale) (Giardini et al., 2019), a nationally recognized tool and validated scale to describe
disease progression in PD (Martinez-Martin et al., 2018), that is reported by a primary care
doctor.
Included in this study were individuals with mild to moderate PD (H&Y scale
stages 1-4) that were ambulatory, were not participating in intensity-based exercise
routines and where not currently receiving any physical therapy. Excluded in this study
were individuals with severe PD (H&Y scale stage 5) and those individuals that had recent
cardiac and/or orthopedic problems that limited mobility. Individuals with severe PD were
excluded because the outcomes chosen for this study were validated only in the mild to
moderate diseases severity range.
After initial screens on potential participants were completed by the primary
investigator (PI), selected individuals were called by the PI to schedule an introduction
session. During this first session, the PI described the study and obtained a signed consent
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form from individuals that were interested in participating. Also, during this this session,
participants were introduced to the equipment and the lab space that would be utilized for
the study. All participating individuals had to obtain a physician’s clearance prior to start
of program. Finally, a baseline cognition screen was completed by the PI for each
participant using the Montreal Cognitive Assessment (MOCA) at the conclusion of the first
session. The MOCA is a widely used cognition assessment for individuals with PD that
has a total of 30 points, with lower scores reflecting cognitive decline (Fengler et al., 2016).
The MOCA is validated in the PD population to assess for cognition and a cutoff score of
less than 26/30 has been established to identify individuals with PD with cognitive deficits
(Dalrymple-Alford et al., 2010). Table 4.1 provides demographics information for all
individuals that participated in the study.
Table 4.1 Demographics
Participant
1
Age
71

2

3

4

5
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76

68

65

Sex

Female

Female

Male

Male

Male

# Years with PD

9

14

2

9

11

PD Severity
(H&Y Stage)
MOCA score

Mild
(2)

Moderate
(4)

Mild
(1)

Moderate
(3)

Moderate (4)

29/30

30/30

29/30

27/30

16/30

yes

yes

yes

yes

Currently
medication
management
PD

on
for
yes
of

Materials
Baseline, intervention, and withdrawal conditions were conducted by the primary
investigator, who had 10 years of experience working with the neurological population as
a licensed physical therapist. The study took place at the Stone Family Center at the
University of Evansville in Indiana (see figure 1). A manual electric treadmill was utilized
with an overhead body weight support system (BWS) to provide support, confidence and
reduce the risk for falls (see figure 2 and 3). A Polar H10 heart rate chest strap monitor was
used to record heart rate and outcome measures of intensity during exercise (Hinde et al.,
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2021; Muggeridge et al., 2021). An additional polar H10 monitor phone application
provided real time recordings of heart rate during exercise and time that was spent in
designated exercise intensity zones. For mobility outcome assessments, only a stopwatch
and measuring wheel was required (Moore et al., 2018).
Figure 4.1 Stone Family Health Sciences Lab
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Figure 4.2 Treadmill Setup

Figure 4.3 BWS

Procedures
To control for procedural infidelity, adherence to implementation measures were
maintained throughout study (Portney & Watkins, 2000). A predetermined criteria
48

checklist of all procedures was placed in the file of each participant, which contained both
a list of setup procedures and explicit outcome of interest. Checklists were reviewed prior
to each session to maintain integrity of data collection To avoid threats to internal validity,
each phase was continued until stability was reached to avoid learning effects (Portney &
Watkins, 2000). A novel treadmill platform was only used during condition B1 and B2
intervention phases to reduce carryover effects.
Baseline and Withdrawal Phases (A1, A2): During baseline and withdrawal phases
only outcomes were collected and no moderate intensity treadmill intervention included.
These sessions were shorter (around 20 minutes) and the next phases were initiated after
predictable and stable data was present during conditions. Withdrawal periods included
immediate removal of the moderate intensity -based walking program. Individuals were
instructed to continue to participate in normal activities for daily living during these
periods.
Intervention Phase (B1, B2): Intervention phases included a 30-minute
individualized moderate intensity driven treadmill walking program. Initial treadmill
speeds were set at predetermined individualized gait speed levels obtained from baseline
10-meter walk test results. The 10MWT test is the gold standard to record walking speed
for community dwelling individuals (). Heart rate maximum was calculated (HrMax= 208
– (.7 x age) and used to set a target moderate intensity heart rate goal at 65% of an
individual’s HrMax (Jonas & Phillips, 2009). Heart rate was monitored closely by Polar
H10 Heart Rate Sensors (Polar) throughout intervention phases. No participants were
currently taking beta blockers that would blunt cardiovascular response. Forward walking
at increased treadmill speeds and increased incline was manipulated to reach the target
heart rate zones. If additional challenges were needed to reach target heart rate, lower
extremity weights were added to provide walking with resistance. Rate of Perceived
Exertion (RPE) was also used to assess perceived intensity levels and were targeted at 1417 (hard to very hard). The RPE scale is a 15 point scale with verbal descriptors to
standardize perceived exertion across tasks and has been validated as a useful tool to
measure intensity of exercise in individuals with PD (Penko et al., 2017). Once target heart
rate was reached, participants were encouraged to stay at that moderate intensity level for
the session. Safety protocols were in place throughout intervention phases including close
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monitoring of response to exercise. Exercise was discontinued if vital signs fell outside the
recommended cardiovascular guidelines (American College of Sports et al., 2018) or if
RPE scores were higher than 17. Each participant completed a total of 16 moderate
intensity -based treadmill exercise sessions which met the minimum recommended
guidelines for cardiovascular benefits of endurance exercise (American College of Sports
et al., 2018)
Environment
All sessions (baseline, intervention, and withdrawal periods) were conducted oneon-one with a physical therapist. Each participant enrolled in the study had intentions to
improve their walking ability. A body weight support system was utilized during all
treadmill sessions to only provide support with no de-weighting applied to the individual.
The BWS harness helped to reduce fear of falling during intervention trials, improve
confidence in exercise, and provide an overall safe environment to exercise. Body weight
support ambulation training has been well established as an effective intervention strategy
in a variety of neurological populations by providing a controlled reduction in weight
bearing which allows for improved postural support and coordination of the lower
extremities (Field-Fote & Tepavac, 2002; Hesse et al., 1997; Miller et al., 2002). Though
this study did utilize reduction in weightbearing, the harness a lone provided a controlled
environment that increased confidence by providing a safe environment to practice walking
(Hesse et al., 1997). BWS addresses posture, balance and coordination in a safe, efficient
and task-oriented manor.
Sessions included verbal guidance throughout conditions on outcome performance
and progress made during sessions. One-on-one verbal motivation was delivered
throughout as well to promote encouragement, point out accomplishments, and discuss
overall progress in achievable goals. Reaching the target heart rate zones was encouraged
during the intervention periods and participant goals were set during sessions to increase
duration in the cardiovascular zones. Each participant was made aware of the target heart
rate goal for the desired moderate intensity level for each session. Throughout the session,
the participant had both a visual reminder of what their current heart rate was as well as
verbal reminders from the PT. Encouragement was given once individuals reached their
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target heart rate zone to continue to work at that level to induce a positive cardiovascular
response. The study design allowed for individuals to experience changes in endurance that
were presented to them in session updates at the beginning and end of sessions. Each
participant was made aware of the progress on desired outcomes to fuel motivation in
achieving improved endurance throughout the study.
Outcomes
Outcomes of interest were selected from the neurological core set of clinical
measures published by Moore et al. (2018). These guidelines were set forth to not only
streamline assessments utilized across patients with neurological conditions but to quantify
function in the constructs that are representative of everyday life (Moore et al., 2018). All
the measures selected are recommended by the Academy of Neurological Physical Therapy
and assess aspects of gait, balance and endurance that can be collected during physical
therapy sessions without use of specialized equipment (Moore et al., 2018). They provide
a clinical meaningful picture of functional mobility for individuals with a neurological
diagnosis.
The core set included the 6MWT, 10MWT, Functional Gait Assessment (FGA),
Five Time Sit To Stand (5xSTS) and the Activities Of Balance Confidence (ABC).
Additional measures included the TUG and the TUG Cognitive which are recommended
by the American Physical Therapy Association’s (APTA) Academy of Neurology to assess
balance for individuals with PD. Table 4.2 describes each measure in detail with
implementation procedures, definitions and published minimal detectable changes, if
available. Implementation of these selected outcome measures followed protocols and
procedures that were outlined in recently published clinical practice guidelines for
individuals with neurological disorders (Moore et al., 2018).
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Table 4.2 Protocols and Minimal Detectable Changes (MDC) for All
Secondary Outcome Measures of Interest
Outcome Measurement Procedure
6MWT
Endurance
Total distance (meters) an participant can
walk over level surfaces with any assistive
device or bracing that they are currently
using. Walking is completed in a set circuit
(12 meters forward walking with a turnaround
point that is 49 inches wide).
10MWT
Gait speed
Fastest
and
safest
walking
speed
(meters/second) over a 6-meter pathway on
level surfaces (with a 2-meter warm up and 2meter slowdown that is pre marked)

Primary and
MDC
82 meters
(Steffen &
Seney,
2008)
.18m/s

(Steffen &
Seney,
2008)
FGA
Gait balance A 10-item assessment that measures postural 4 points
and function
stability and balance during functional
mobility tasks. A total of 30 points is possible, (Petersen
with each item scored on a 0-3 ordinal scale. et al., 2017)
Higher scores indicating good balance.
5XSTS
Lower
The amount of time it takes to complete 5 .6 seconds
extremity
stands without upper extremity support from (SEM)
endurance
a sitting position in a standard chair with or
without arm rests, that is not supported and (Paul et al.,
has a height of 43-45 cm. Participant must 2012)
complete stands without touching the back of
the chair and come to a complete stand (full
extension of legs). Timer is started when the
command “Go” is given and stopped when
the individual’s buttocks touch the chair.
The total time it takes to rise from a chair,
walk 3 meters (at a comfortable pace), turn,
TUG/
Balance
walk back to the chair and sit down. Test is .8/6.7
TUG
completed in a 9.8 feet walkway with a (SEM)
(cognitive)
standard chair (height 46 cm with arm rests).
Timer is started when the command “Go” is (Paul et al.,
given and stopped when the individual’s 2012)
buttocks touch the chair.
TUG cognitive requires the participant to
complete the above TUG test while counting
backwards from a random number, starting
with 100.
PDQ-39 – Quality of Life 39 item self-report that assesses PD specific
mobility
health related quality in multiple life 12.4
subscale
dimensions, including functional mobility
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Balance
confidence

ABC

assessments. The functional mobility
subscale is represented by items 1-10 and are
assumed to impact QOL. Scoring is a 5-point
ordinal scale for each item, with 0 indicating
never and 4 indicating always. Lower scores
reflect better QOL.
Self-reported measured of balance confidence
during activities of daily living. Each item is
rated on a 0% to 100% whole number rating
scale, where zero represents no confidence
and 100% is total confidence.

(Fitzpatrick
et al., 2004)

13%
(Steffen &
Seney,
2008)

Primary outcome measure: 6MWT. The 6MWT is the gold standard measure to
assess an individual’s gait endurance. The 6MWT measures functional capacity at
submaximal exercise levels, which reflects effort used in normal daily activities (Moore et
al., 2018). The 6MWT has good test-retest reliability (ICC = .95-.96) and has been found
to be responsive to change after exercise interventions within the PD population (Steffen
& Seney, 2008). The 6MWT was completed at the start of every session across all phases
in this study.
Secondary outcome measures: cardiovascular metrics of intensity, clinical gait
outcomes, quality of life. Core set measures were collected once at the baseline phase and
then a second time at the end of the study. Specific clinical gait outcomes were selected
from the neurological core set (Moore et al., 2018), which included the 10MWT, FGA,
5xSTS and ABC. The TUG, an assessment of a dual task gait parameter, was also added
to secondary outcomes. The TUG (both regular and cognitive) is recommended by the PD
EDGE task force in the neurological section of the APTA is a validated tool in this
population (Paul et al., 2012). The PDQ-39 (Bushnell & Martin, 1999) was included to
assess overall quality of life and was broken down to assess the mobility aspects
specifically. Cardiovascular measures were recorded with the Polar H10 application.
Average heart rate, maximum heart rate, distance walked, and time spent in target moderate
intensity heart rate zones were recorded during intervention phases. Moderate intensity
zones of exercise were defined as work at 65-80% of an individual’s maximum heart rate
where maximum intensity zones incorporate levels above 80% (American College of
Sports et al., 2018; Hornby et al., 2019)
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Qualitative Interviews: Finally, at the conclusion of the intervention a descriptive
qualitative study was completed to understand the experience of participating in the
selected intervention from the perspective of the participant.
Data Analysis
Visual analysis of 6MWT performance, our primary measure, was conducted both
within and between conditions (Portney & Watkins, 2009). Within condition visual
analysis included assessing data level, trend, variability, and stability. Data level was
defined as the amount or magnitude of the outcome measure, which is often described as
low, moderate or high (Scruggs & Mastropieri, 1998). Trend refers to slope (either steep
or gradual) and direction (either therapeutic or countertherapeutic) of the data points that
are moving over time (Scruggs & Mastropieri, 1998). Variability is the fluctuation from
one data point to the next within a phase which can be represented by a range whereas
stability is demonstrated by predictable and consistent data values within a condition
(Scruggs & Mastropieri, 1998).
To determine if there was a significant change in 6MWT performance visual
analysis between conditions was also analyzed by assessing immediacy of change and data
overlap. Immediacy of change is the degree to which there was a change in 6MWT
performance as soon as the moderate intensity driven walking intervention was introduced,
which is described as delayed or immediate (Kennedy, 2004). Immediate changes indicate
a more powerful effect of the intervention (Kennedy, 2004). Data overlap refers to the
values of data in one condition that are in the same range of values of data in the adjacent
condition, which is often reported as a proportion (Kennedy, 2004).
In conjunction with visual analysis, the two standard deviation band method was
completed to determine the level of significance between endurance and the proposed
intervention. Two standard deviation lines above and below the calculated means for each
participant was marked on each graph. According to this method, if over half the data points
in the intervention period fall above these lines, the difference in the intervention phase is
significant at the p<.05 level (Portney & Watkins, 2009).
Lastly, visual analysis results were summarized and interpreted to draw conclusions with
goals to determine if there was a presence of a functional relationship between an moderate
54

intensity walking intervention and 6MWT performance. A functional relationship is
defined as a definite demonstration that the intervention produced reliable and consistent
changes in the outcome measure of interest, which is described 3 clear demonstrations of
change in the 6MWT scores throughout the study (Kennedy, 2004).
For remaining secondary outcome measures, scores produced were compared to MDCs
(standard measures of error, SEM, were also used if an MDC wasn’t available) and
significance was determined if minimal scores were reached or above the threshold for
error.
Results
The primary purpose of this study was to determine if participation in an moderate
intensity -based walking intervention had an effect on walking endurance for individuals
with PD. All five individuals completed a total of 24 sessions, 4 times a week over a 6week period, with 100% completion. This included 8 baseline sessions and 16 moderate
intensity -based intervention sessions.
Baseline Endurance: Endurance deficits were apparent in our small sample size of
participants with mild to moderate PD and provided an opportunity to trial an intervention
to improve this deficit. Participants 1 and 3 walked 338 and 351 meters during the 6MWT
which fell below the 70-79 year old age matched range of 471-527 meters (Steffen et al.,
2002). Participants 4 and 5 6MWT distances of 389 and 243 meters also fell below the 6069 year old age matched values range of 538-572 meters (Steffen et al., 2002). And finally
participant 2, who was the only one with young onset PD, had a minimum 6MWT distance
of 271 meters which fell below normative 6MWT for this age group at 593 meters (Chetta
et al., 2006).
Primary Outcome Measures –6MWT: Figures 4.4 (a-e) present 6MWT
performances for each participant in the moderate intensity driven walking program. A
range of 8,839 meters to 11, 887 meters was achieved on 6MWT distances across
participants during all conditions. All five participants saw a positive improvement on their
6MWT after completion of the intervention when compared to baseline reaching with
participant 1 reaching a minimum gain of 172 meters and participant 3 reaching a
maximum gain of 669 meters from baseline. Four out of five participants reached published
55

PD MDCs for the 6MWT by gaining an additional 82 meters and exceeded the MDC with
gaining an average of 163 meters (min= 127.4, max=203.9) across participants. Participant
1 demonstrated improvements on the 6MWT but fell short of the MDC by 30 meters.

Figure 4.4 (a-e) A-B-A-B 2 Standard Deviation Band Plots for 6MWT Distances per
Session for Participants 1(a), 2(b), 3(c), 4(d), 5(e).
6MWT,
Baseline Mean
Average,
+SD and - SD

Distance walked (meters)

Participant 1 6MWT (a)
400
390
380
370
360
350
340
330
320
310
300

1 2 3 4

5 6 7 8 9 10 11 12

13 14 15 16

17 18 19 20 21 22 23 24

Sessions

Distance walked (meters)

Participant 2 6MWT (b)
450
400
350
300
250
200

1 2 3 4

5 6 7 8 9 10 11 12

13 14 15 16

Sessions
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17 18 19 20 21 22 23 24

Distance Traveled (meters)

Participant 3 6MWT (c)
585
565
545
525
505
485
465
445
425
405
385
365
345
325

1 2 3 4

5 6 7 8 9 10 11 12

13 14 15 16

17 18 19 20 21 22 23 24

Sessions

Distance Traveled (meters)

Participant 4 6MWT (d)
510
490
470
450
430
410
390
370
350

1 2 3 4

5 6 7 8 9 10 11 12

13 14 15 16

17 18 19 20 21 22 23 24

Sessions

Distance Traveled (meters)

Participant 5 6MWT (e)
500
450
400
350
300
250
200
150
100

1 2 3 4

5 6 7 8 9 10 11 12

13 14 15 16

Sessions
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17 18 19 20 21 22 23 24

Visual analysis of 6-minute walk test distances across participants revealed that a
moderate intensity -based walking program had significant effects on participants
endurance. Within condition analysis demonstrated immediate changes in 6MWT data
trends in which the slope of the lines showed clear changes within each condition. Both
therapeutic trend changes within conditions during intervention phases and a
countertherapeutic trend changes during withdraw periods was reflected in the slope across
all participants. There was also a gradual decelerating response with removal of the
walking program in condition B2. However, there was a demonstration of retained
endurance gains at the conclusion of the second intervention phases across participants
which was reflected in 6MWT test scores that never returned to baseline performances.
Participant 4 was the only exception, who suffered an orthopedic injury not related to the
study and fell below baseline during withdrawal period. Average 6MWT distances for
participant 4 were as follows: A1 (1,424m), B1 (1,467m), A2 (1,325m), B2 (1506m).
Though there was a decrease noted after the first intervention condition secondary to injury
there was still a notable improvement after the participant was feeling better, with higher
distances achieved when the intervention was implemented again.
Between condition visual analysis revealed both immediate changes in level of
6MWT distances after implementation of a moderate intensity-based walking intervention.
Furthermore, immediacy of change across adjacent conditions was demonstrated, with an
abrupt change in 6MWT distances, that was most notable after just one moderate intensity
-based treadmill session.
Confidence of a behavior change, defined as changes in the 6MWT, was
strengthened by not only the abrupt changes in level but also by the decreased overlap of
data between conditions. The percent of nonoverlapping data ranged from 70-90% and
according to Scruggs et al., percent of nonoverlapping data levels above 70% suggests that
the intervention effectiveness was effective to very effective (Scruggs & Mastropieri,
1998).
In conjunction with visual analysis, the two standard deviation band method was
also utilized to assess significance of the intervention. A range of 9 -19 sessions above
baseline mean performance, with at least two consecutive data points in the intervention
phase fell outside the band for all individuals. Two consecutive data points outside the band
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suggests that the change in behavior (Scruggs & Mastropieri, 1998), in this case the
improvement noted on the 6MWT, exceeds chance and was due to the intervention
provided. This concludes that there was a significant change from baseline endurance when
participating in this moderate intensity -based exercise program.
The consistency in level change between conditions, the high percentage of
nonoverlapping data and amount of data points that fall outside the two standard deviation
band supports a presence of a functional relationship between moderate intensity -based
exercise and 6MWT endurance across all participants.
Secondary Outcome Measures - Cardiovascular Measures of Intensity:
Participation in moderate exercise was well tolerated throughout the intervention phases for
individuals with both mild and moderate PD with no adverse reactions or dropouts.
Individuals were able to tolerate moderate intensity zones (65-75% HRmax) for at least 25
minutes with some participants reaching 28 minutes out of a 30-minute session with
reported RPE ranges from 15-17. Only participant 2 was able to reach levels of high
intensity (75-85% HRmax) for a total of 10 minutes over a total of 480 minutes of
intervention.
Secondary Outcome Measures – Neurological Core Set: Changes from pre
intervention to post in the secondary outcomes of interest that were chosen from the
neurological core set, as well as the TUG were calculated, and compared to established
MDCs reported in the literature. Table 4.3 presents data for all secondary outcome measures
including minimal and maximal performances, pre and post intervention differences as well
as compared results to published MDCs within the PD population.
Table 4.3 Pre and Post Intervention Results
Participants
Participant Participant
1
2
6MWT
(meters)
Minimum
338
271
Maximum
390
398
Change
(+)52
(+)127
MDC
no
yes
10MWT
(m/s)

for Neurological Core Set Outcomes Across
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Participant
3

Participant
4

Participant
5

351
555
(+)204
yes

389
504
(+)115
yes

243
451
(+)208
yes

PreIntervention
Post
Intervention
Change
MDC
PDQ39(mobility)
PreIntervention
Post
Intervention
Change
MDC
5xSTS
(seconds)
PreIntervention
Post
Intervention
Change
SEM
FGA
PreIntervention
Post
Intervention
Change
MDC
TUG/TUG
Cognitive (s)
PreIntervention
Post
Intervention
Change
SEM
ABC (%)
PreIntervention
Post
Intervention
Change
MDC

1.17

1.07

1.31

1.23

0.97

1.66

1.66

2.21

2.41

1.20

(+)0.49
yes

(+)0.59
yes

(+)0.90
yes

(+)1.18
yes

(+)0.23
yes

22.5

47.5

2.50

32.5

52.21

14.5

22.5

0

17.5

33.21

8
yes

25
yes

2.50
no

15
yes

19
yes

13.57

11.86

5.05

12.89

15.15

9.7

9.18

4.82

11.95

12.58

(+)3.87
yes

(+)2.68
yes

(+)0.24
no

(+)0.94
no

(+)2.57
yes

25

24

28

25

17

30

28

30

28

21

(+)5
yes

(+)4
yes

(+)2
no

(+)3
no

(+)4
no

10.2/12.09

9.61/10.5

6.21/7.41

9.15/12.54

8.74/16.48

8.36/9.17

6.99/7.86

5.05/5.49

6.61/7.62

8.63/11.55

(+)1.84/2.92 (+)2.62/2.64 (+)1.16/1.92 (+)2.54/4.92 (+)0.11/4.93
no/no
no/no
no/no
no/yes
no/yes
62.25

66.25

98.75

62.8

83.75

76.19

71.6

99.39

83.75

64.38

(+)13.94
yes

(+)5.35
no

(+)0.61
no

(+)20.95
yes

(+)18
yes
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10MWT, FGA and the ABC all demonstrated improvements in scores with
implementation of an moderate intensity -based walking program across participants. At
least 3 out of 5 participants reached MDC levels for both the FGA and ABC. 10MWT
improvements reached MDC for all participants. Gait speed, measured by the 10MWT, has
been shown to be a powerful predictor of disability, hospitalization and falls (Fritz &
Lusardi, 2009). Participants 1, 2, 3 and 4 gait speeds (1.17 m/s, 1.07 m/s, 1.23 m/s, 0.97
m/s) fell below a cutoff of 1.3 m/s which has been established as the speed needed to fully
participate in community based ambulation activities such as crossing a street or climbing
a flight of stairs (Fritz & Lusardi, 2009). After participation in an moderate intensity driven
walking program, all these participants reached gait speeds above thresholds to access full
community mobility (1.66 m/s, 1.66 m/s, 2.41 m/s, 1.20m/s)
Further analysis revealed that participant 5’s initial gait speed of .97 m/s, the
slowest out of all 5 participants at baseline, categorized this participant as a limited
community ambulator who was more at risk for requiring assistance for ADLs and more
likely to be hospitalized or have an adverse health problem in the future (Fritz & Lusardi,
2009). Participant 5, after intervention, improved his gait speed to 1.2 m/s which now
provided him with the speed that is required to be a full community ambulator (Fritz &
Lusardi, 2009).
In addition to the neurological core set, the TUG, TUG cognitive and the 5xSTS
were added to secondary measures. The Academy of Neurology recommends these
outcome measures to be collected for individuals with PD and are included in the APTA
EDGE documents that identify outcomes to assess functional mobility potential. The TUG,
TUG cognitive scores and 5xSTS did show improvements after intervention but did not
produce MDCs from baseline.
Secondary Outcome Measures – QOL: The PDQ-39 was administered to assess
quality of life after participation in an moderate intensity driven walking program. This
study chose to only focus on the mobility subscale secondary to selected outcomes of
interest looking at functional mobility as the primary goal. Analysis of the PDQ-39
mobility subscale, a scale that assesses percentage of perceived disability from 0% (no
impairments) to 100% full impairment, revealed that 4 participants that had detected
mobility QOL impairments at baseline (range 22.5% - 55.21%) reached minimal detectable
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thresholds after participation in an moderate intensity driven intervention program. An
average improvement of 16.75% was noted for participants 1,2,4 and 5 on mobility
subscale questions. Specifically, question number 5 asks, “Due to having PD, how often
during the last month have you had problems with walking a half mile?” (Bushnell &
Martin, 1999) all 4 individuals reported improvement on this question.
Secondary Outcome Measures – Qualitative Interviews: A descriptive qualitative
study, in addition to the PDQ-39 mobility assessment was completed, to further investigate
the nonmotor impacts of PD. Our qualitative study aimed to understand the experience of
participating in an intensity-based exercise program from the perspective of the individual.
The goal was to understand what and how they experienced the impact of our intervention.
Open ended interview questions (see table 4.4) were asked following the conclusion of the
study and participants were asked to schedule for one final visit after their last session was
completed. Interviews were held in the research laboratory where the study took place and
remarks were transcribed verbatim by the primary investigator. Specific questions focused
on how individuals felt after participating in an intensity-based intervention and if they
perceived any notable changes during their daily routines.
Table 4.4 Qualitative Interview Questions
• Can you describe for me what did it feel like to practice walking at an increased
intensity level?
• How would you describe your current endurance level?
• Have you noticed any changes in your daily routines since starting this in
program?
o If yes, can you give me an example of when you noticed a difference in
your daily routines?
• Tell me about your overall experience towards this type of intervention?
• To what extent has this exercise opportunity impacted your quality of life?
Thematic analysis was conducted following the interviews to search and identify
common threads that were used to describe the overall experience of participating in a
moderate intensity walking program across all 5 participants (Colorafi & Evans, 2016).
Analysis revealed four emerging themes common across the 5 participants which included
overcoming fear, accountability, improvement, and confidence.
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Theme 1 - Overcoming fear: Our participants were generally at first hesitant about
trying a new, unfamiliar exercise intervention. Feelings of fear and uncertainty were
expressed with trying something that was not a part of their daily routines which made
them also feel nervous at the start of the study. Doubt of individual abilities was also a
common occurrence when asked about the experience of participating in a walking
program that was going to be delivered on a treadmill. None of the 5 participants had
previously used a treadmill for exercise. The fear of not knowing what to expect and of the
possibility of failure was a common theme throughout the interviews. However, the sense
of accomplishment after completing the intervention was reflected in the strength and
surprise of being able to achieve exercise levels that were at first thought to be impossible.
The participants expressed:
o
o
o
o

“Scared that it was going to be challenging but it wasn’t too bad”
“It was hard at first then got easier”
“I wasn’t able to walk as far from the start but then I surprised myself”
“I didn’t think I could but then I was able to finish”

Theme 2 – Accountability: Motivation to participate in our selected intervention
came from not only wanting to improve their walking but also was fueled by adhering to a
responsibility to themselves, the primary investigator, other individuals with PD and their
families. The ability to be a part of a research project gave a purpose to the participants and
held them responsible to fulfilling an obligation. Participant 3 felt that it was his duty to
participate in research opportunities so that other individuals with PD could benefit in the
future. Participant 2 said that her husband has been pushing her to exercise more and used
this as motivation to seek out opportunities that were available in the community. Overall,
the individuals shared:
o
o
o
o
o
o

“I didn’t want to let you down”
“I want to keep it up, it has been good for me”
“If I can help someone else with PD then it was worth it”
“I want to work out because I have somewhere to go”
“My husband has really been on my case about exercising more”
“COVID shut my world down. This gave me a purpose”

Theme 3 – Improvement: Overall, the experience of this intervention was well
received which was made apparent in the activities that were now possible or easier since
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starting the intervention. Functional mobility gains were noted in routine activities that
were meaningful to the participants. When asked about changes and activities they could
now do the participants stated:
o
o
o
o
o
o

“I am able to walk my dog more”
“I can get around the block faster than I did”
“My balance feels better”
“Getting up from a chair is easier”
“I lost weight”
“I can walk across a street faster in a big city”

Theme 4 – Confidence: Finally, there was a notable increase in daily life confidence
that was not only reflected in personal experiences but from the perspective of surrounding
family members as well. When asked what was different now in their daily lives after
participating in this study, the participated noted:
“I can walk to the parking lot without getting out of breath”
“My family noticed I wasn’t so tired”
“I can now cross the street faster with my son”
“My husband was surprised that I mowed the lawn for the first time in 4
years”
o “I can get the mail without getting tired and help around the house”
o
o
o
o

A comprehensive understanding of personal benefits that were achieved at the end
of our study was reflected not only in the qualitative remarks but in the quantitative
improvements on both PDQ-39 and ABC scores. All 5 participants demonstrated improved
scores on both the PDQ and ABC, with at least 3 out of 5 participants reaching established
MDC. Overall, participants overcame fear and doubt about participating in a new intensity
driven exercise program by utilizing motivation found within themselves and others around
them to achieve salient improvements in their daily lives.
Discussion
The purpose of this research was to trial a moderate intensity driven walking
program provided in an environment with opportunities to boost self-efficacy and its
impact on endurance as well as other clinical measures of functional mobility. The results
of our study found that individuals who demonstrated baseline endurance deficits
demonstrated improvements in endurance measures as well as other clinically meaningful
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outcomes after participating in a moderate intensity driven walking program that had
opportunities to improve individual self-efficacy.
Interventions targeting improving endurance: With implementation of an moderate
intensity driven walking intervention, each participant demonstrated steady therapeutic
improvements in endurance measures with maintained gains in the second intervention
phase. Slight decreases in endurance after removal of the intervention during withdrawal
periods were quickly regained with more gait practice. Quantifiable, clinical detectable
changes in distance traveled ranged from 172 feet to 669 feet (Steffen & Seney, 2008).
Improvements in endurance are possible and individuals with PD may need to be pushed
at higher intensity levels beyond their voluntary limits at rates sufficient to induce gait
performance changes. Immediate endurance responses during conditions for all
participants as well as little overlapping data suggest that the use of a moderate intensity
driven intervention to target endurance for individuals with PD may improve desired
outcomes.
The Importance of a supportive environment: Important to note is the strategic
environment that was set up for delivery of the intervention. Individuals were given an
opportunity to work one-on-one with a PT that had experience in working with individuals
with neurological disorders. There are many local community exercise programs in the
area that offer group-based exercise to improve flexibility, balance, and overall strength
for individuals with PD. These groups usually are run by volunteers from a variety of
backgrounds that have general knowledge in exercise. Group programs available, to our
knowledge, do not offer opportunities to specifically work on walking in an environment
that provides weight supported options to improve confidence in exercise programs.
Though community groups provide a viable option for exercise, individualized PT
exercise, when compared to the other group or self-prescribed exercise, has been found to
show substantial improvements in functional and balance outcomes for individuals with
PD (King et al., 2015). In addition, the American Academy of Neurology advocates not
only for individuals with PD to participate in exercise to manage symptoms of PD, but also
recommended regular physical therapist assessments to be completed at least twice a year
(Cheng et al., 2010). Our study provided an opportunity for individualized sessions from a
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neurological specialist PT that had knowledge in gait, mobility, and PD specific
interventions.
Treadmill as an option to deliver endurance interventions: Worthy to note was the
improvement after the first single session of moderate intensity -based exercise, with each
participant gaining a minimum of 50 meters of distance with one participant gaining over
162 meters. A change of 54-80 meters on the 6MWT has been established as a minimal
clinically important difference (MCID) within the geriatric and stroke population (Wise
& Brown, 2005). Though we do not know the MCID for PD, we can draw on other
populations and find the importance of gaining an average of 50 meters in a single
intervention session. Pohl et al. (2003) found similar results finding immediate benefits in
gait biomechanics, such as step length, as early as 24 hours post walking training with
individuals with PD. Choosing to deliver this intervention on a treadmill could have
contributed to these quick gains in endurance. Step training with a treadmill platform has
been established as both a feasible and safe option for individuals with PD to practice
intensity based and walking in multiple studies with little adverse reactions or dropouts
reported (Clarke et al., 2016; Frenkel‐Toledo et al., 2005; Ridgel et al., 2015; Ridgel et al.,
2008; Schenkman et al., 2017). Treadmill practice utilizes both visual and verbal cuing to
improve gait abnormalities that are present with stepping practice that provides external
sensory cueing to help augment the deficient internal cueing with PD (Frenkel-Toledo
2005). This platform provides an option with constant feedback to improve walking
endurance in a controlled environment. Moderate intensity -based walking on a treadmill,
with an environment that provides confidence in exercise, may provide a solution to
achieve walking endurance in an efficient amount of time.
Intensity of Practice: Practicing walking at moderate levels of intensity was thought
to also be a contributing factor to not only endurance gains but other clinical gait outcomes.
Walking at moderate intensity levels was sufficient to produce changes in walking
endurance, walking speed and produce perceived levels of increased intensity that were
reflected in high RPE scores. Walking speeds reached MDC (Morey et al., 2017) for all
individuals and gains were noted to reach higher level community walking speeds that were
not possible before the start of the study. Walking speed has been suggested as contributor
to fall risk, hospitalization and community mobility (Morey et al., 2017) Providing the
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opportunity to walk at increased levels of intensity seems to play a role in a positive impact
on not only gait endurance but gait speed in order to access the community.
To date, few studies have attempted to use moderate intensity treadmill training and
only one study has challenged individuals at high-intensity levels (Schenkman et al., 2017).
When compared to a control group or usual care, intensity-based training has improved
UPDRS motor scores, Vo2 max, and cadence as well as specific gait parameters such as
variability, step length and arm swing (Ridgel & Ault, 2019; Ridgel et al., 2015; Ridgel et
al., 2008). Stepping practice at high-intensity levels of 80% of heart rate max or higher was
found to also be well tolerated with minimal adverse effects and produced a reduction in
scores on the UPDRS motor scale (Schenkman 2017). Though the proper dose of intensity
is still unclear, it is clear that moderate intensity-based exercise plays a pivotal role in
improving gait and should be an option for exercise over usual care or low intensity
exercise. This study found that moderate levels of intensity were sufficient to achieve gains
in endurance and other selected outcome measures of interest.
Specificity and Repetition of Practice: In addition to intensity, neuroplastic
principles of specificity and repetition were also implemented during this study (Kleim &
Jones, 2008). Our study utilized task specific training by utilizing an intervention that
targeted walking for those individuals that wanted to improve their walking. In addition,
providing an opportunity to practice walking in a repetitive way, at a higher level of
intensity, may have also provided an efficient solution to improve clinical meaningful gait
outcomes for individuals with PD. Drawing on other neurological populations, the number
of steps taken is directly related to walking recovery, with higher intensity stepping practice
yielding the best outcomes (Moore et al., 2020). The daily step count for individuals with
PD tends to decrease with physical activity levels reaching 30% less with disease
progression (Cavanaugh et al., 2015; Ellis et al., 2013). On average, individuals with PD
take 2,300 less steps than their age-matched peers (Lord et al., 2013). Decreased activity
levels increase the risk for future cardiovascular disease and further disability (Park et al.,
2020). Our study provided an opportunity to increase steps per day with participants
averaging 32,062 total meters of distance traveled on the 6-minute walk test across
conditions (range: 28,354-39,013 meters). In addition, participants walked a minimum of
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16.67 miles up to 26.43 miles for total moderate intensity stepping during interventions
phases.
Addressing the multifactorial impact of PD on functional mobility: Our study found
that utilizing an intervention that addressed not only the motor symptoms, but the
multifactorial components of PD as well, provided the optimal solution to addressing this
variable disorder. By addressing individual self-efficacy through safety mechanisms,
mastery of experiences and positive verbal persuasion, we were able to motivate exercise
participation.
Providing an environment that was safe was implemented to attempt to reduce
exercise induced anxiety. Utilizing a body weight support (BWS) harness provided a
mechanism in which individuals with PD could exercise without the fear of falling or losing
their balance, both common subsequent complications of this disorder (Bloem et al., 2004).
BWS has been shown to reduce dropout rates, improve mobility and decrease overall
anxiety with exercise practice in other neurologic populations (Sharan et al., 2016).
In addition to providing a safe environment, opportunities to improve both
confidence and motivation were included that were delivered by the PT to boost participant
self-efficacy. Self-efficacy, rather than disability, appear to be strongly associated with
whether ambulatory individuals with PD exercise regularly and those that demonstrate poor
motivation tend to exercise less (Ellis et al., 2011). The selection of a single subject design
boosted motivation for individuals in which they were to complete against themselves.
Session updates throughout the study provided individuals with up-to-date progress on
outcome measures that they could see being graphed. Verbal motivation provided by the
PT during sessions gave structured goals that were obtainable, and reminders of how hard
individuals were working. This attention provided to improve participant self-efficacy
drove motivation to continue with the exercise program which was evident in the zero
attrition rates of this study. Both motor and nonmotor factors needs to be addressed to see
substantial improvements in functional mobility for individuals with PD.
Impact on QOL after addressing both motor and nonmotor symptoms of PD:
Finally, the impact of addressing this multifactorial disorder was reflected in the gains
noted in quality of life. This was another focus of our study because QOL has been reported
to be highly correlated with motor impairments involving difficultly with walking,
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speaking, and maintaining balance (Tu et al., 2017). In addition, nonmotor symptoms of
cognition, stigma, body discomfort and emotional well-being have also been identified as
key contributors to QOL (Tu et al., 2017). This again reinforces the importance of
recognizing both the motor and nonmotor symptoms of PD and providing options to target
all aspects of this progressive, neurodegenerative disorder that currently has no cure.
After participation in a moderate intensity driven exercise intervention our study
found that 4 out of the 5 of the participants reported substantial changes in their functional
mobility QOL Improvements across all 5 participants were noted on item number 4, “Have
you had problems walking a mile” and item number 7 “Have you had difficulty getting
around in public”. Both questions identify the importance of endurance to participate in
activities outside the home. It seems to be that the gains made after participating in the
study not only improved confidence in distance but were also able to be generalized to
daily functional mobility activities that are required to be independent in the community.
The increased confidence in functional mobility was reflected in significant gains made on
the PDQ-39 and provides an understanding of the impact of this program on overall
perceived quality of life.
Qualitative Remarks: Qualitive reflections provided by our participants
strengthened our confidence that our intervention had a meaningful impact on daily lives.
Addressing self-efficacy throughout our intervention allowed individuals to overcome
fears about trying new evidence-based exercise interventions to combat this multifactorial
disability. Addressing possible sources for anxiety by providing a supportive environment
that included individualized assistance and a body weight support to reduce the fear of
falling allowed participants to focus on improving motor impairments.
Motivation to improve was provided not only from the primary investigator but
surrounding support systems that were already in place for the participants. Neurological
disorders, especially PD being progressive, not only impacts the individual but the
surrounding family as well. Even though there were significant changes noted on the PDQ39 mobility scale scores to draw attention to improved quality of life, the biggest gains
were heard in the verbal improvements in daily activities that included family involvement.
Though participants all mentioned positive changes in their day, participant 2 demonstrated
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one of the most substantial differences that was reflected from a family members
perspective. Participant 2 mentioned:
“I can’t believe it. I was able to keep up with my son for the first time while crossing the
street to his soccer game and walking across the field to where he needed to meet his team.
I wasn’t out of breath and could hold onto a conversation with him about his excitement
for the evening and what the game plan was. For the first time, in a long time, I don’t think
he was embarrassed to be seen with me. I just felt normal”.
Qualitative remarks from participant 2 remind us of the daily struggles that
individuals with PD face. Living with PD is a life altering disorder that can result in social
embarrassment that may be from motor symptoms, non-motor symptoms, loss of
autonomy, or from the need for help (Angulo et al., 2019). Regardless of the source, all
these factors impact not only QOL but activities that were once able to be completed
without any struggle that allowed for family. To fully address the multifactorial impact of
PD, interventions need to target all aspects of this disorder to see optimal results and return
some control back into lives that have been turned upside down from this progressive
neurological disorder.
Limitations
Several limitations should be considered when interpreting the results of this study.
Most importantly, though the strongest rigor design was chosen for this single subject
design, external validity is still limited due to the small sample size. However, there was
direct intra-participant replication achieved which will allow for future larger studies to
replicate the results for clinical use. Also, inter-observer agreement and procedural
reliability was not collected concurrently throughout conditions which could have
strengthened the validity of study finds. However strict adherence to published outcome
protocols was present to control for errors in testing. Finally, the 5 individuals chosen for
this study were in the mild to moderate stages of PD and were highly motivated. This may
have contributed to their reported adherence and future studies may need to look at
motivational differences in individual presentations of PD to understand the impact of this
intervention for all levels of disease severity.
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Conclusions
These findings support the implementation of a moderate intensity driven exercise
to improve endurance and other gait performance measures for individuals with PD in a
structured environment that provides opportunities to improve self-efficacy. Future
research is needed to replicate these results to a larger population and to seek out other
opportunities for moderate intensity-based walking that do not require a controlled
laboratory setting to provide real world opportunities for this type of practice.
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CHAPTER 5. SUMMARY
Summary of Study 1 & 2
The overall purpose of this research was to first explore the exercise habits of
individuals with PD to understand what type of exercise was being utilized to combat this
progressive neurodegenerative disorder that currently has no cure. It aimed to understand
how intense individuals perceived their workouts and what barriers existed to PD related
symptom management. This research then aimed to use this knowledge about exercise
habits and couple it with current best evidence to develop an intervention that targeted
improving clinically meaningful outcomes with goals to address the multifactorial
components of PD.
Study 1: Investigating the current perceived exercise habits, frequencies, and intensities of
individuals with PD living in the community and identifying barriers to exercise.
AIM: Investigate the current perceived exercise habits, frequencies, and intensities of
individuals with PD living in the community and understand the barriers to exercise
training.
Methods: One hundred thirty-eight individuals with PD living in the community completed
our 22-question online survey that aimed to understand current function, exercise habits
and perceived levels of exercise intensity during daily routines.
Hypothesis: Individuals living in the community with PD will report participating in
exercise and describe experiencing intensity-based symptoms only some of the time during
routine exercise.
Results: The hypothesis was accepted. Eighty-seven percent of our respondents did report
participating in some form of exercise that was most common in a group setting (67%,
n=97). However, despite practicing in exercise habits, notable impairments in walking
were reported. Specifically, impairments in both walking endurance and walking speed
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were the two most common deficits present. Furthermore, eighty-one percent of these
individuals perceived themselves at exercising with moderate intensity, but then when
asked about symptoms that would reflect a challenging workout (such as sweating,
shortness of breath, muscle soreness or fatigue), they did not report these symptoms often.
In fact, these symptoms were reported either never or only sometimes (less than half the
time) during routine workouts. In addition to exercise habits, the most common reported
barriers to exercise were fear of falling (72%, n=99), assistance from another person
required(61%, n=84), lack of equipment (45%, n=62) and knowledge limitations regarding
what to do for exercise (75%, n=103).
Summary: The results of this survey demonstrate that individuals with PD are seeking out
opportunities to participate in exercise to manage symptoms of this progressive disorder
but may not be selecting the individualized options to improve walking specifically. There
is strong evidence supporting the use of task specific exercise at moderate to high
intensities to improve locomotor function for individuals with neurological disorders
(Hornby et al., 2019). Our results indicate that participants are selecting more group-based
activities, but they are also not working out at moderate intensity levels. There was a clear
mismatch between perceived levels of intensity and actual exercise induced symptoms that
would reflect a challenging workout. Reported barriers to exercise such as fear of falling,
lack of awareness and education on what type of exercise one should be participating in to
improve their walking performance may be contributing factors to this mismatch that was
demonstrated in our results. Addressing these barriers in future exercise options may help
individuals with PD manage their symptoms and overall functional mobility.
Emerging Clinical Themes from Study 1:
•

Selected exercise habits are not directly targeting gait impairments that are present
in individuals with PD.

•

Individuals with PD may not be exercising at challenging enough intensities to
produce symptoms that are consistent with moderate to high intensity exercise.
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•

More education is needed regarding intensity levels of exercise and the benefits of
pushing oneself past voluntary limits to improve gait performance within the PD
population.

•

Barriers to exercise for individuals with PD, such as fear of falling and confidence,
need to be addressed to optimize clinical based outcomes.

Study 2: The effectiveness of a moderate intensity driven walking program in targeting the
multifactorial components of PD with goals to improve clinically meaningful outcomes.
AIM: Determine the effectiveness of a moderate intensity driven walking program that
targets the multifactorial components of PD with goals to improve clinically meaningful
outcomes.
Methods: 5 individuals with PD participated in a single subject A1-B1-A2-B2 withdrawal
design intervention study that addressed both the motor and nonmotor aspects of PD. After
baseline outcomes were collected (A1), each participant participated in an intensity-based
walking intervention twice (B1, B2) that was separated by a withdrawal condition (A2)
which included removal of the intervention. The selected intervention included a 30-minute
individualized intensity treadmill walking program that was driven by a predetermined
heart rate goal set at a minimum of 65% of an individual’s heart rate maximum (Jonas &
Phillips, 2009) to incorporate higher levels of intensity walking practice. To address
common nonmotor components of PD (Martikainen et al., 2006) opportunities were
provided to boost individual self-efficacy, or confidence, throughout the study. A body
weight support harness was utilized to reduce fear of falling during intervention trials, oneon-one

verbal

motivation

was

delivered

throughout

sessions

to

recognize

accomplishments. Reaching target heart rate zones was encouraged during the intervention
to draw attention to progress in personalized goals. The primary outcome variable was the
6-minute walk test (6MWT) to assess endurance. Secondary clinically meaningful
outcomes, selected from the neurological core set (Moore et al., 2018), were also collected
to understand the impact of moderate intensity-based walking on these outcomes. Core set
outcomes included the 10-meter walk test (10MWT), functional gait assessment (FGA),
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and activities of balance confidence (ABC). In addition, the TUG to assess balance and the
Parkinson’s disease questionnaire (PDQ-39) to assess quality of life were collected.
Hypothesis: Individuals living in the community with PD will demonstrate improvements
in clinically meaningful outcomes after participating in a moderate intensity-driven
walking intervention when compared to baseline. The following questions, breaking down
the overarching hypothesis, aimed to address the multifactorial components of PD:
•

Is there is a functional relationship between intensity step training program and gait
endurance for individuals living in the community with PD?

•

Does an intensity step training program influence secondary clinically meaningful
outcomes, such as speed and balance, with individuals living in the community with
PD?

•

Can an intensity step training program that is provided in an environment that
incorporates opportunities for improved self-efficacy generalize to improvements
to perceived quality of life in individuals living in the community with PD?

Results: The overarching hypothesis was accepted, and all the specific questions of interest
were answered following this study. All participants demonstrated a positive improvement
in clinically meaningful outcomes following participation in this study. Endurance,
measured by the 6MWT, improved for all individuals when compared to baseline with
individuals walking an average of 463 meters when comparing the difference between
minimal and maximum distances traveled. Four out of 5 participants reached published
MCD for the 6MWT by gaining at least an additional 82 meters after participation in the
intervention (Steffen et al., 2002). Further visual analysis revealed both therapeutic trend
changes within conditions during intervention phases and countertherapeutic trend changes
during withdrawal periods that provide confidence in significant effects on participants
endurance. The consistency in level change between conditions of the study, high
percentage of nonoverlapping data (range 70-90%), and amount of data points that fall
outside the 2 standard deviation band method of analysis (range 9-19 sessions) supports a
presence of a functional relationship between intensity-based exercise and 6MWT
endurance across all participants.
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Our results indicated that there was also an influence on secondary clinically
meaningful outcomes for individuals with PD after participation in this study. Specifically,
scores on the 10MWT, the FGA, and the ABC all demonstrated improvements in scores
with implementation of an intensity-based walking program across participants. TUG
scores improved but did not reach significance.
Finally, our study found improvements in perceived quality of life, measured by the PDQ39. Analysis of the PDQ-39 mobility subscale, a scale that assesses percentage of perceived
disability from 0% (no impairments) to 100% full impairment, revealed that 4 participants
that had detected mobility QOL impairments at baseline (range 22.5% - 55.21%) reached
minimal detectable thresholds after participation in an intensity driven-intervention
program (Bushnell & Martin, 1999).
Summary: The results of this study support the utilization of a moderate intensity driven
walking program provided in an environment to boost self-efficacy as a possible
intervention to improve clinically meaningful outcomes for individuals living in the
community with PD. Functional mobility measures as well as quality of life for individuals
with PD all responded positively to an intensity driven exercise program. Intense exercise
was well tolerated, and one-on-one sessions provided opportunities to boost confidence
and self-measurable goals. Intensity-driven exercise is an option to improve endurance and
other gait performance measures for individuals with PD in a structured environment that
provides opportunities to improve self-efficacy.
Emerging Clinical Themes from Study 2
•

Improvements in endurance are possible for individuals with PD that have deficits
in functional mobility. Interventions targeting endurance should be included in the
exercise prescription for those that demonstrate deficits at baseline.

•

Treadmill stepping practice may provide the optimal solution for quick gains in gait
performance measures when time is a factor in selecting appropriate interventions
for individuals with PD.

•

Individuals with PD may need to be pushed at higher intensity levels beyond their
voluntary limits at rates sufficient to induce gait performance changes.
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•

Inclusion of specific interventions that target walking in a repetitive manor should
be included for those individuals that express goals of improving their walking.

•

Addressing confidence and safety, providing individualized encouragement, and
setting attainable personalized goals may help address multifactorial symptoms of
PD and provide opportunities to improve overall quality of life.

Synthesis of Results
Current PD management prioritizes the use of pharmacology interventions that only
address the motor aspects of PD (Mercuri & Bernardi, 2005). However, PD needs to be
recognized not only for the motor symptoms but the multifactorial components that impact
living with this progressive disorder (Martínez-Martín, 1998). Nonmotor symptoms
include, but are not limited to taste changes, bowel and bladder dysfunction, memory loss,
trouble concentrating, loss of interest, hallucinations, and sleep disturbances. In addition,
neuropsychological symptoms of depression and anxiety disorders occur in a significant
proportion of individuals with PD and are positively correlated with motor symptoms,
motor complications, gait difficulties, freezing episodes, on-off fluctuations, cognitive
impairment, disability, worsening quality of life, and poor self-perceived health status
(Dissanayaka et al., 2010; Pontone, 2017; Starkstein & Merello, 2002). Moving away from
the old medical model views and adapting the perspective derived from the ICF model that
emphasizes the holistic person (Martínez-Martín, 1998) can provide a new perspective to
PD care that creates additional solutions for lifelong management.
Utilizing the ICF model as a foundation, the addition of exercise that incorporates
both personal and environmental influences of disability to current pharmacology
treatment may provide the optional solution for individuals with PD to regain control .
Given that PD is an uncurable progressive disorder individuals can feel a loss of hope and
autonomy. (Sjödahl Hammarlund et al., 2018). This loss of control then requires a
dependence on others which can be viewed as a burden and can leave individuals with a
loss of identity (Sjödahl Hammarlund et al., 2018). Adding exercise opportunities can
provide a choice in management for PD to combat this multifactorial disorder which would
improve confidence and control in daily activities.
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The results of this research emphasize the importance of providing exercise options
that target all aspects of PD in an individualized environment. Our survey identified that
many of our respondents were participating in group-based exercise opportunities that are
the most widely available options for individuals with PD living in the community. But
despite these current exercise habits, individuals with PD still reported deficits in walking
ability. Community options that provide group environments for exercise are beneficial at
working to address generalized impairments such as whole body strengthening or
flexibility. However, it may be beneficial to seek out additional individualized
opportunities that specifically target impairments that are impacting walking.
In addition to an individualized environment, this research found that incorporating
interventions that draw on neuroplastic principles such intensity, repetition, and salient
activities also need to be implemented to see the greatest benefits in clinically meaningful
outcomes.
It has been established that exercise practiced in repetition and at increased
intensities is the most beneficial option for those with neurological deficits that want to
improve walking function as well as other clinically meaningful outcomes (Hornby et al.,
2019). Our results in study 1 indicate that these strategies are underutilized in current PD
practice. Less than 5% of our surveyed population used their heart rate to monitor exercise
intensity and most individuals were not working out at efforts high enough to induce
intensity-based symptoms.
Identifying what individuals were currently not doing for exercise in study 1 helped
tailor the intervention to address the specific needs of the PD population in study 2 and
gaps in exercise opportunities. Delivering higher intensity exercise, pushing beyond
voluntary limits, is an option that is has been well tolerated for individuals with PD and we
found this to be true in our study as well, which is reflected in our zero attrition rates. In
addition, only a handful of studies have trialed intensity-based exercise with this population
(Clarke et al., 2016; Frenkel‐Toledo et al., 2005; Ridgel & Ault, 2019; Schenkman et al.,
2017) with similar results and overall good tolerance reported. This well tolerated
intervention that emphasized evidence-based practice strategies contributed to the
significant gains we were able to achieve across our participants. Individuals with PD could
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benefit from education regarding the need to exercise at higher intensity levels to see
meaningful changes in their daily activities.
Providing education regarding what environment and type of exercise are most
beneficial may still have its limitations if all aspects of PD, especially the nonmotor
symptoms, are not addressed. Self-efficacy, rather than disability, appear to be strongly
associated with whether ambulatory individuals with PD exercise regularly, and those that
demonstrate poor motivation tend to exercise less (Ellis et al., 2011). Interventions need to
incorporate opportunities to improve confidence in managing PD and boost motivation. If
there is not a desire to exercise, then interventions created will not provide benefit.
Incorporating opportunities to improve self-efficacy may be the additional component to
improve motivation to exercise in order to achieve gait performance changes. Our
interventions provided a one-on-one enriched environment with a physical therapist that
implemented safety techniques throughout to reduce anxiety and provided participants with
positive verbal feedback which helped not only achieve individualized goals but spark
confidence and motivation. This attention to the environment and personal factors, coupled
with the best evidence-based exercise, contributed to the significant improvements in our
study and needs to be a component in future studies in PD management.
Clinical Application of Results
PD is an incurable, progressive neurological disorder that will require adherence to
lifelong strategies for symptom management. As a clinician, providing the most beneficial
interventions for individuals with PD is challenging due to the variety of symptoms that
encompass this disorder and the hidden nonmotor symptoms that are beneath the surface.
Our first study identified that individuals with PD are exercising but not in a supportive
environment with opportunities to address all aspects of PD. We also learned from our first
study that individuals with PD reported the burden of nonmotor symptoms that included
both fear and dependence on others when participating in exercise interventions. Our
second study demonstrated that if we provide interventions that address these multifactorial
components of PD by utilizing best evidence-based practice, in an environment that allows
for close monitoring of progress and addresses nonmotor personal factors such as fear and
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confidence, then we can make substantial improvements on not only gait performance
measures but also overall quality of life.
The optimal solution to addressing the variability of PD and the variety of
symptoms that accompany this disorder is to approach interventions from a multifactorial
standpoint (see Figure 5.1). Adapting the ICF models framework we can recognize that
PD, a multi factorial disorder (noted on the left side of the model), requires a multifactorial
intervention (represented on the right side of the model). Based on the results of this
research, we suggest utilizing interventions that address all aspects of PD including body
function impairments, activity limitations, and overall decreased life participation.
Approaching these impairments as a combination of limitations that directly impacts
functional mobility is required rather then addressing them as single units.
Figure 5.1 Changing the Perspective of PD Management: Proposed Exercise Theory to
Target the Multifactorial Components of PD as an Adjunct to Gold Standard Care

Our proposed model (see Figure 5.1) suggests a guide to selecting appropriate
interventions for this population that may be helpful. When addressing functional mobility
impairments for individuals with PD, we recommend utilizing a multifactorial approach as
an adjunct to gold standard pharmacology care (L-Dopa). First, exercise interventions
should utilize strategies that are recommended by current evidence-based research, such as
increasing intensity and repetition of practice to induce clinically meaningful changes.
Second, exercise interventions should be delivered in an environment that provides an
80

opportunity to be one-on-one with a physical therapist that has expertise in functional
mobility, which is also recommended to occur yearly by the American Academy of
Neurology (Cheng et al., 2010) to provide guidance and monitoring of progressive
symptoms Finally, interventions must also address personal factors of PD and consider
boosting self-efficacy to improve motivation and confidence in exercise self-management.
By utilizing this optimal multifactorial approach, interventions can target the holistic
individual with PD. We feel that these recommendations depicted in our model provide the
most beneficial option for selecting interventions that aim to achieve clinically meaningful
outcomes for individuals with PD.
Both motor and nonmotor impairments associated with PD directly affect one’s
functional mobility potential, but the relationship between personal factors and exercise
offers optimism for both individuals with PD and clinicians treating this disorder. This
relationship suggests that to change exercise behavior we must address the personal factors
that contribute to the decline in functional mobility. If we can exhibit control over one’s
exercise behavior then we can improve symptoms, regardless of the defined disability.
When designing intervention programs for individuals with PD, the following
recommendations based on this research are suggested to reach optimal achievable
outcomes:
•

For individuals that present with walking and endurance deficits, trial walking
practice at higher intensity levels to induce gait performance changes.

•

Utilize specific individual goals to create salient activities that will improve
motivation to participate in exercise.

•

Provide education regarding evidence-based interventions that are available for
individuals for PD to improve their functional mobility potential.

•

Address the multifactorial impact of PD in selected interventions to optimize best
outcomes.
Our research brought attention to not only the need for a multifactorial intervention

approach for individuals with PD but also demonstrated the importance of delivering
these interventions in a supportive environment that is driven by a PT. Moving forward,
changing the conversation regarding management of PD and including the need for
annual PT assessment needs to be included. Routine PT visits can provide assessments
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of current functional status, monitoring of symptom progression and recommendations
for lifelong management strategies. Adhering to these recommendations from a PT,
that are considered mobility experts on the healthcare team, can provide the confidence
and support that is needed for this population to make adjustments to routine exercise
habits that are practiced and help manage the progressive nature of PD.
Limitations & Future Research
The research that has been presented in these studies comes with limitations that
can be addressed in future research. First, both our survey and intervention study were
completed utilizing a small sample which could indicate that our results could have limited
external validity. However, now that the intervention has been trialed, a future larger study
would help strengthen the recommendations and results to a larger population. Second,
though this research suggests that a moderate intensity is beneficial for individuals with
PD to see gait performance changes, the proper dosage is still poorly understood with this
population. Comparing different levels of intensity (low, moderate, and high) in a larger,
more heterogenous sample would provide more guidance on the proper dosage of intensitybased exercise that is required to see improvements.
Furthermore, these studies provided only a snapshot in time with long-term benefits still
unknown. It would be helpful in future research to incorporate a follow up period to
determine if endurance gains as well as secondary outcomes of interest were maintained
long term. Finally, future research trialing this intervention in additional environments that
did not require treadmill usage could help provide additional exercise options for those
individuals that do not have access to equipment. Implementing this intervention in an
environment that individuals must encounter everyday could help reflect everyday life with
PD.
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APPENDICES

APPENDIX A. STUDY 1 SURVEY
Start of Block: Consent

Consent Form
Perceived exercise habits of individuals living with Parkinson’s disease in the
community Primary Researcher: Dr. Jordana Lockwich PT, DPT
Department: Physical Therapy
We are inviting you to participate in a short research study (10 minutes or less). Your
participation is completely voluntary. If you decide to participate in the survey, you are
free to withdraw at any time.
The goal of this online survey is to understand what you have been doing for exercise
over the past 6 months. We are asking you to participate because you have been
diagnosed with Parkinson’s disease.
Although your answers to these questions may be published, no information that could
identify you will be included. There is no risk or cost to you for participating in this
study. Your answers will be stored in a password protected file and will then be deleted
once the study has concluded.
Any questions regarding this study should be directed to: Jordana Lockwich PT, DPT
jlo269@uky.edu
We appreciate your participation and thank you! Sincerely,
Dr. Jordana Lockwich Physical Therapist, PhD Student, Rehabilitation Sciences,
University of Kentucky
By clicking YES below, you are consenting to participate
in this survey. (after click the right arrow at the bottom of the screen to begin)

o Yes, I agree to participate (1)
o No, I don't agree to participate (2)
End of Block: Consent
Start of Block: Demographics
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D1 How old are you?

o (1)
o 50-59 (2)
o 60-69 (3)
o 70+ (4)
D2 How many years have you been living with Parkinson's disease?

o < 1 year (1)
o 2-4 years (2)
o 5 years (3)
o >6 years (4)
D3 What is your gender?

o Male (1)
o Female (2)
o Gender variant/ non conforming (4)
o Other (5)
o I prefer not to answer (6)
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D4 What is the highest level of education that you have completed?

o did not finish highschool (1)
o high school (2)
o some college (3)
o bachelor's degree (4)
o graduate/advanced degree (5)
D5 What is your current living situation?

o I live alone (1)
o I live with others (family, significant other, guardian) (2)
o I live in a healthcare facility (assisted living/skilled nursing home) (3)
o Other (please specify) (4)
________________________________________________
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D6 How would you describe your current Parkinson's disease symptoms?

o Mild (no signs/symptoms0 (1)
o Mild (with symptoms on one side of your body) (2)
o Moderate (with symptoms on both sides of body but can walk by myself) (3)
o Advanced (severe symptoms but can still walk or stand unassisted) (4)
o Advanced (unable to walk, spend most of the day in bed or a wheelchair) (5)
o I don’t know (6)
D7 Do you take medication for your Parkinson’s Disease?

o Yes I take medication for my Parkinson's Disease (1)
o No I do not take medication for my Parkinson's Disease (2)
o I don't know (3)
Display This Question:
If Do you take medication for your Parkinson’s Disease? = Yes I take medication for my Parkinson's
Disease

D7.1 How many years have you been taking your Parkinson's medication? (type below)
________________________________________________________________
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D8 Have you had a deep brain stimulation procedure to treat your Parkinson’s disease
symptoms?

o Yes, I have had Deep Brain Stimulation (1)
o No, I have not had Deep Brain Stimulation (2)
End of Block: Demographics
Start of Block: Current Level of Function

Normal Day Block
The following questions aim to understand
how you currently go about your normal day with Parkinson’s disease
over the last 6 months:

N9 Do you need any physical help from another person during your typical day?

o Yes, I need help from another person to participate in my day (1)
o No, I do not need help from another person. I can participate in my day on my
own. (2)
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N10 Describe how you walk on a typical day:

o On my own (no assistance from a device and/or another person) (1)
o With an assistive device (walker, cane, brace, etc.) (2)
o With help from another person (3)
o I cannot walk (4)
N11 Describe your walking:

o My walking is the same as it has been before my diagnosis with Parkinson's
disease (1)

o My walking has changed (gotten better) since I have been diagnosed with
Parkinson's disease (2)

o My walking has changed (gotten worse) since I have been diagnosed with
Parkinson's disease (3)

Display This Question:
If Describe your walking: = My walking has changed (gotten worse) since I have been diagnosed with
Parkinson's disease
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N11.1 How has your walking changed? (choose all that apply)

▢

I have difficulty maintaining my balance with walking (grass, uneven
sidewalks, carpet, stepping over objects, etc) (1)

▢
▢
(4)

▢
▢
▢

I am unable to walk long distances for long time because I get tired (2)
I have pain or stiffness in my joints/body that makes my walking difficult

I feel weak when I walk (6)
I walk slower than I used to (8)

Other (type below) (5)
________________________________________________
End of Block: Current Level of Function
Start of Block: Exercise Habits

Exercise Habit Block
The following questions are asking about your
current exercise habits with Parkinson's disease
over the past 6 months:

E12 Do you currently exercise?

o Yes (1)
o No (2)
Skip To: End of Survey If Do you currently exercise? = No
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E13 Do any of the following impact your ability to exercise? (choose all that apply)

▢
▢
▢
▢
▢
▢

I want to exercise but I don’t know what to do (1)
I want to exercise but I need someone to help me (2)
I don’t have any transportation to go somewhere to exercise (3)
I am afraid of exercising because I might get hurt or fall (4)
I don’t have the equipment to exercise (5)

Other (type below) (6)
________________________________________________

E14 Where do you workout most of the time?

o At home (1)
o Outside the home (2)
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E15 Who do you exercise with most of the time?

o Alone (1)
o With another person (2)
o A group with healthy individuals that do not have Parkinson's Disease
o A group with individuals that have Parkinson's Disease (4)
o Healthcare workers and/or therapists (5)
o Mix of the above (please explain below) (6)

(3)

________________________________________________

E16 What do you choose to work on when you exercise? (choose all that apply)

▢
▢
(1)

▢
▢
▢
▢

Getting better at maintaining my balance (3)
Building up my endurance so I can exercise for a longer period of time

Stretching (4)
Improving my strength in my arms, legs and body (2)
Mixed program (5)
Other (6) ________________________________________________
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E17 How long do you typically exercise for in a single session?

o (1)
o 15-30 minutes per session (2)
o 31-45 minutes per session (3)
o 46 minutes-1 hour per sessions (4)
o more than one hour per session (5)
E18 How many times do you typically exercise per week?

o 1-2 sessions per week (1)
o 3-4 sessions per week (2)
o 5+ sessions per week (3)
E19 Do you walk for exercise?

o Yes (1)
o No (2)
o I don't consider walking as exercise

(3)

Display This Question:
If Do you walk for exercise? = Yes
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E19.1 Where do you walk for exercise? (choose all that apply)

▢
▢
▢
▢
▢

On level surfaces (1)
On uneven surfaces (3)
On a Treadmill (2)
Inside the house (4)
Outside the house and in the community (5)

End of Block: Exercise Habits
Start of Block: Exercise Intensity

Intensity Block
The following questions are intended to understand
how much effort you are putting into your exercise
over the past 6 months:

I20 How would you describe your exercise intensity?

o My workout intensity is light (hardly any exertion, can maintain for hours, easy to
breath and carry conversation) (1)

o My workout intensity is moderate (breathing heavy, can hold short conversation,
still comfortable but becoming more challenging) (2)

o My workout intensity is vigorous (borderline uncomfortable, short of breath, can
speak only a sentence) (3)
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I21 Do you mointor your heart rate while exercising?

o Yes (1)
o No (2)

I22
How likely are you to experience the following while exercising:

Never (22.1)

Sweating (1)
Shortness of
Breath (2)
Fatigue (3)

Soreness (4)
Stop exercise
due to
symptoms (5)

About half
the time
(22.3)

Sometimes
(22.2)

Most of the
time (22.4)

Always
(22.5)

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

End of Block: Exercise Intensity
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Start of Block: COVID-19

COVID block The following questions are asking about how your
current exercise habits have adapted
due to the current coronavirus (COVID-19) pandemic:

C23 Has your exercise routine been impacted by the coronavirus (COVID-19) pandemic?

o Yes (1)
o No (2)
o I don’t exercise

(3)

Display This Question:
If Has your exercise routine been impacted by the coronavirus (COVID-19) pandemic? = Yes

C23.1 Describe how your exercise has changed due to the current coronavirus (COVID19) pandemic?
________________________________________________________________
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C24 My exercise intensity during the current coronavirus (COVID-19) pandemic is:

o My workout intensity is light (hardly any exertion, can maintain for hours, easy to
breath and carry conversation) (1)

o My workout intensity is moderate (breathing heavy, can hold short conversation,
still comfortable but becoming more challenging) (2)

o My workout intensity is vigorous (borderline uncomfortable, short of breath, can
speak only a sentence) (3)

C25 How long do you typically exercise during the current coronavirus (COVID-19)
pandemic?

o (1)
o 15-30 minutes per session (2)
o 31-45 minutes per session (3)
o 46 minutes-1 hour per sessions (4)
o more than one hour per session (5)
C26 How many times do you typically exercise per week during the current coronavirus
(COVID-19) pandemic?

o 1-2 sessions per week (1)
o 3-4 sessions per week (2)
o 5+ sessions per week (3)
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APPENDIX B. SURVEY INFORMED CONSENT
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APPENDIX C. INTERVENTION INFORMED CONSENT
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APPENDIX D. INTERVENTION DATA SHEET
Participant #1
Max Heart Rate (220-age)
Target High Intensity HR
Initial

Final

Session 1

Session 2

PDQ-39
ABC
10MWT
FGA
5xSTS
TUG
TUG cognitive
6MWT
Duration of Sesion
HR maxx
Average Heart Rate
Total Distance
Time Spent to reach target HR
Time Spent in target HR
# Rest Breaks Taken
RPE
5 minutes
10 minutes
15 minutes
20 minutes
25 minutes
30 minutes
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Session 3

Session 4

APPENDIX E. NEUROLOGICAL CORE SET OUTCOME: 6MWT PROTOCOL
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APPENDIX F. NEUROLOGICAL CORE SET OUTCOME: 10MWT PROTOCOL
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APPENDIX G. NEUROLOGICAL CORE SET OUTCOME: FGA PROTOCOL
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APPENDIX H. NEUROLOGICAL CORE SET OUTCOME: 5XSTS PROTOCOL
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APPENDIX I. NEUROLOGICAL CORE SET OUTCOME: ABC
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APPENDIX J. PDQ-39
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